<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Cellular and Infection Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Infect. Microbiol.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2235-2988</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcimb.2026.1740531</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title><italic>Glaesserella parasuis</italic> infection disrupts the gut&#x2013;lung axis via microbiota dysbiosis and metabolic reprogramming leading to intestinal barrier impairment in piglets</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name><surname>Li</surname><given-names>Na</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn003"><sup>&#x2020;</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name><surname>Shen</surname><given-names>Aobo</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn003"><sup>&#x2020;</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Sun</surname><given-names>Xinlu</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Guo</surname><given-names>Ying</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project-administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Yin</surname><given-names>Ronglan</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project-administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Qian</surname><given-names>Meiling</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Zeng</surname><given-names>Fanhua</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Wang</surname><given-names>Haoran</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Liu</surname><given-names>Xueqian</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Li</surname><given-names>Menglu</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Zhou</surname><given-names>Yuanyuan</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>*</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project-administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Yin</surname><given-names>Ronghuan</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>*</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/3015058/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project-administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label><institution>Key Laboratory of Livestock Infectious Diseases, Ministry of Education, and Key Laboratory of Ruminant Infectious Disease Prevention and Control (East), Ministry of Agriculture and Rural Affairs, College of Animal Science and Veterinary Medicine, Shenyang Agricultural University</institution>, <city>Shenyang</city>,&#xa0;<country country="cn">China</country></aff>
<aff id="aff2"><label>2</label><institution>State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory of Zoonosis Research, Ministry of Education, Jilin University</institution>, <city>Changchun</city>,&#xa0;<country country="cn">China</country></aff>
<author-notes>
<corresp id="c001"><label>*</label>Correspondence: Yuanyuan Zhou, <email xlink:href="mailto:zhouyy26@syau.edu.cn">zhouyy26@syau.edu.cn</email>; Ronghuan Yin, <email xlink:href="mailto:yrh2018@syau.edu.cn">yrh2018@syau.edu.cn</email></corresp>
<fn fn-type="equal" id="fn003">
<label>&#x2020;</label>
<p>These authors have contributed equally to this work</p></fn>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-02-05">
<day>05</day>
<month>02</month>
<year>2026</year>
</pub-date>
<pub-date publication-format="electronic" date-type="collection">
<year>2026</year>
</pub-date>
<volume>16</volume>
<elocation-id>1740531</elocation-id>
<history>
<date date-type="received">
<day>06</day>
<month>11</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>19</day>
<month>01</month>
<year>2026</year>
</date>
<date date-type="rev-recd">
<day>11</day>
<month>01</month>
<year>2026</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2026 Li, Shen, Sun, Guo, Yin, Qian, Zeng, Wang, Liu, Li, Zhou and Yin.</copyright-statement>
<copyright-year>2026</copyright-year>
<copyright-holder>Li, Shen, Sun, Guo, Yin, Qian, Zeng, Wang, Liu, Li, Zhou and Yin</copyright-holder>
<license>
<ali:license_ref start_date="2026-02-05">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<sec>
<title>Background</title>
<p><italic>Glaesserella parasuis</italic> (<italic>G. parasuis</italic>), is a key respiratory pathogen responsible for Gl&#xe4;sser's disease in pigs, characterized by polyserositis, arthritis, and pulmonary lesions. While it disrupts the respiratory microbiota, its impact on the gut-lung axis, a critical pathway for systemic immune and metabolic crosstalk, remains unexplored.</p>
</sec>
<sec>
<title>Methods</title>
<p>We established a piglet infection model using the highly virulent G. parasuis strain XX0306 (serotype 5). Systemic effects were investigated through integrated 16S rDNA sequencing of the lung and gut microbiota, complemented by untargeted metabolomics of intestinal contents. We performed histopathological examination and measured serum biomarkers (diamine oxidase and D-lactate) to assess intestinal barrier integrity. Correlation analysis linked microbial shifts to host metabolic alterations.</p>
</sec>
<sec>
<title>Results</title>
<p>Infection induced profound dysbiosis in both the lung and gut microbiota. Pulmonary microbial diversity and functional potential declined. Gut dysbiosis featured a loss of beneficial bacteria and enrichment of potential pathogens (e.g., <italic>Streptococcus</italic>, <italic>Campylobacter</italic>, <italic>Desulfovibrio</italic>). Functional prediction indicated significant alterations in 12 gut microbial metabolic pathways, with downregulated amino acid metabolism and upregulated carbohydrate/lipid metabolism and xenobiotic degradation. Metabolomics identified 30 differentially abundant metabolites (e.g., argininosuccinate, liquiritigenin, citrulline), primarily enriched in cytochrome P450-mediated xenobiotic metabolism and arginine biosynthesis. Argininosuccinate levels correlated with pathogenic genera (<italic>Leucobacter</italic>, <italic>Streptococcus</italic>, <italic>Desulfovibrio</italic>). Infected piglets exhibited significant intestinal barrier damage, evidenced by elevated serum diamine oxidase (DAO) and D-lactate (D-LA).</p>
</sec>
<sec>
<title>Conclusion</title>
<p>This study demonstrates that <italic>G. parasuis</italic> infection extensively remodels the gut-lung axis microbiota and host metabolome, leading to intestinal barrier impairment. The perturbation of arginine biosynthesis may compromise host immunity. These results provide novel mechanistic insights into the pathogenesis of Gl&#xe4;sser's disease.</p>
</sec>
</abstract>
<abstract abstract-type="graphical">
<title>Graphical Abstract</title>
<p>
<fig>
<graphic xlink:href="fcimb-16-1740531-g000.tif" position="anchor">
<alt-text content-type="machine-generated">Graphic illustrating the impact of *G. parasuis* infection in piglets on lung flora and gut-lung axis. Top section shows changes in microbial diversity, highlighting Proteobacteria and Firmicutes increase, while Cyanobacteria and Bacteroidetes decrease. The middle section describes the infection process, emphasizing the gut-lung connection. The bottom section details intestinal microbiota alterations and related metabolic pathways, including xenobiotic metabolism by cytochrome P450 and arginine biosynthesis. Various metabolites and bacteria influencing these processes are depicted.</alt-text>
</graphic>
</fig>
</p>
</abstract>
<kwd-group>
<kwd><italic>Glaesserella parasuis</italic></kwd>
<kwd>microbial dysbiosis</kwd>
<kwd>gut-lung axis</kwd>
<kwd>metabolomics</kwd>
<kwd>arginine biosynthesis</kwd>
<kwd>intestinal barrier dysfunction</kwd>
</kwd-group>
<funding-group>
<award-group id="gs1">
<funding-source id="sp1">
<institution-wrap>
<institution>National Natural Science Foundation of China</institution>
<institution-id institution-id-type="doi" vocab="open-funder-registry" vocab-identifier="10.13039/open_funder_registry">10.13039/501100001809</institution-id>
</institution-wrap>
</funding-source>
<award-id rid="sp1">32172861</award-id>
</award-group>
<award-group id="gs2">
<funding-source id="sp2">
<institution-wrap>
<institution>Natural Science Foundation of Liaoning Province</institution>
<institution-id institution-id-type="doi" vocab="open-funder-registry" vocab-identifier="10.13039/open_funder_registry">10.13039/501100005047</institution-id>
</institution-wrap>
</funding-source>
<award-id rid="sp2">2021-MS-221</award-id>
</award-group>
<award-group id="gs3">
<funding-source id="sp3">
<institution-wrap>
<institution>Scientific Research Fund of Liaoning Provincial Education Department</institution>
<institution-id institution-id-type="doi" vocab="open-funder-registry" vocab-identifier="10.13039/open_funder_registry">10.13039/501100013099</institution-id>
</institution-wrap>
</funding-source>
<award-id rid="sp3">LSNJC201917</award-id>
</award-group>
<funding-statement>The author(s) declared that financial support was received for this work and/or its publication. This work was funded by the National Natural Science Foundation of China (32172861), the Natural Science Foundation of Liaoning Province (2021-MS-221), the Scientific Research Project of Liaoning Provincial Department of Education (LSNJC201917), and the Zoonosis Research Engineering Laboratory Project of Liaoning Province (01072917001).</funding-statement>
</funding-group>
<counts>
<fig-count count="7"/>
<table-count count="6"/>
<equation-count count="0"/>
<ref-count count="46"/>
<page-count count="17"/>
<word-count count="6540"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Veterinary and Zoonotic Infection</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p><italic>Glaesserella parasuis</italic> is an important opportunistic pathogen in swine, capable of causing Gl&#xe4;sser&#x2019;s disease under immunosuppressive or stressful conditions (<xref ref-type="bibr" rid="B15">Jia et&#xa0;al., 2025</xref>). This disease is characterized by fibrinous polyserositis, arthritis, and severe pneumonia, leading to substantial morbidity and mortality, particularly in weaned piglets, and inflicts considerable economic losses on the swine industry (<xref ref-type="bibr" rid="B4">Dazzi et&#xa0;al., 2020</xref>; <xref ref-type="bibr" rid="B9">Gong et&#xa0;al., 2022</xref>). Recent advances in microbiomics have shifted focus towards understanding the pathogen&#x2019;s interaction with the host microbiota. Indeed, previous studies demonstrate that <italic>G. parasuis</italic> infection disrupts the respiratory tract microbiota in piglets, and specific dysbiotic signatures correlate with virulent strain colonization and differential vaccine efficacy (<xref ref-type="bibr" rid="B21">Mahmmod et&#xa0;al., 2020</xref>; <xref ref-type="bibr" rid="B23">Obregon-Gutierrez et&#xa0;al., 2025</xref>). However, this research has been confined to the respiratory niche, presenting a critical limitation.</p>
<p>Gl&#xe4;sser&#x2019;s disease is a systemic condition with multi-organ involvement, suggesting its pathogenesis likely extends beyond local respiratory ecology. In this context, the communication along the gut-lung axis has emerged as a key frontier. This axis involves complex crosstalk: the gut microbiota orchestrates systemic and pulmonary immunity through the maturation and functional programming of key immune cells (<xref ref-type="bibr" rid="B7">Espirito Santo et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B32">Shim et&#xa0;al., 2023</xref>; <xref ref-type="bibr" rid="B33">Stevens et&#xa0;al., 2022</xref>; <xref ref-type="bibr" rid="B40">Yoo et&#xa0;al., 2020</xref>). Conversely, inflammatory signals from the lungs can remodel the gut microbial community, often driving a state of dysbiosis marked by a loss of beneficial symbionts and an expansion of pro-inflammatory taxa, which may compromise colonization resistance and mucosal barrier function (<xref ref-type="bibr" rid="B20">Liu et&#xa0;al., 2024</xref>; <xref ref-type="bibr" rid="B31">Sencio et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B43">Zhang et&#xa0;al., 2022</xref>). Such reciprocal disruption can fuel a vicious cycle of systemic inflammation, potentially exacerbating disease severity (<xref ref-type="bibr" rid="B31">Sencio et&#xa0;al., 2021</xref>). Yet, the functional mediators of this axis in <italic>G. parasuis</italic> infection remain uncharacterized. A growing body of evidence indicates that microbiota exert their influence primarily through metabolic intermediates (<xref ref-type="bibr" rid="B3">Dang and Marsland, 2019</xref>; <xref ref-type="bibr" rid="B41">Yoon et&#xa0;al., 2023</xref>). Microbial metabolites, including short-chain fatty acids, indole derivatives, and bile acids, serve as key signaling molecules (<xref ref-type="bibr" rid="B28">Qayed et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B37">Wei et&#xa0;al., 2023</xref>; <xref ref-type="bibr" rid="B42">Yu et&#xa0;al., 2024</xref>). These metabolites regulate immune homeostasis and mucosal barrier function across distant sites. For example, short-chain fatty acids demonstrate immunomodulatory activity along the gut-lung axis, influencing intestinal permeability and T-cell differentiation (<xref ref-type="bibr" rid="B17">Kim et&#xa0;al., 2013</xref>; <xref ref-type="bibr" rid="B25">Park et&#xa0;al., 2015</xref>). In bronchiectasis, tauroursodeoxycholic acid produced by Eggerthella lenta impairs pulmonary neutrophil function (<xref ref-type="bibr" rid="B36">Wang et&#xa0;al., 2025</xref>). While metabolites such as inosine and short-chain fatty acids modulate anti-tumor immunity and the response to immunotherapy (<xref ref-type="bibr" rid="B45">Zhao et&#xa0;al., 2022</xref>). These research confirmed that specific gut-derived metabolites can dictate pathological outcomes in distal organs.</p>
<p>To determine whether <italic>G. parasuis</italic> infection induces gut-lung axis dysbiosis and metabolic dysregulation, we employed an integrated multi-omics approach in a piglet model. By combining 16S rDNA sequencing with untargeted metabolomics, we comprehensively mapped concurrent compositional shifts in gut/lung microbiota and corresponding alterations in the host metabolome. Our study aims to identify the critical microbial metabolites and associated pathways that contribute to the systemic pathogenesis of Gl&#xe4;sser&#x2019;s disease, thereby providing novel functional insights for future therapeutic interventions.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<label>2</label>
<title>Materials and methods</title>
<sec id="s2_1">
<label>2.1</label>
<title>Bacterial strain and animal infection model</title>
<p>The highly virulent <italic>G. parasuis</italic> strain XX0306 (serotype 5) was preserved by the Laboratory of the College of Animal Science and Veterinary Medicine, Shenyang Agricultural University. The strain was cultured overnight at 37&#xb0;C in tryptic soy broth (TSB, Solarbio, Beijing, China) supplemented with 5% fetal bovine serum (Dingguo, Beijing, China) and 2% nicotinamide adenine dinucleotide (NAD, Solarbio).</p>
<p>Twelve four-week-old piglets were purchased from Shuoyang Breeding Cooperative (Xinmin, China). The experimental protocol was approved by the Ethics Committee of Shenyang Agricultural University (No. 202106034). The piglets were randomly divided into two groups of six each and housed under identical conditions. The infection group was intranasally inoculated with 1 &#xd7; 10<sup>10</sup> CFU of bacterial suspension, while the uninfected group was administered an equal volume of TSB. All piglets were anesthetized with sodium pentobarbital (30 mg/kg, intravenous injection; Sinopharm Chemical Reagent Co., Ltd., Shanghai, China) and euthanized by exsanguination on day 19 post-infection. A complete necropsy was performed immediately. Gross lesions in major organs (heart, liver, spleen, lungs, kidneys, and intestines) were documented photographically.</p>
</sec>
<sec id="s2_2">
<label>2.2</label>
<title>Enzyme-linked immunosorbent assay</title>
<p>Blood samples were collected from the anterior vena cava and left at room temperature for 20 minutes to allow natural coagulation, followed by centrifugation at 3,500 rpm for 15 minutes to separate the serum. Serum levels of inflammatory cytokines interleukin 1 beta (IL-1&#x3b2;), interleukin 8 (IL-8), and tumor necrosis factor (TNF-&#x3b1;) were measured using ELISA kits (Enzyme-linked Biotechnology Co. Ltd., Shanghai, China), strictly following the manufacturer&#x2019;s protocols. Absorbance was measured at 450 nanometers using a microplate reader (Servicebio, Wuhan, China), and a standard curve was generated using the Gen5 software (version 3.11) provided with the instrument to calculate the sample concentration.</p>
<p>Serum markers for intestinal barrier function, diamine oxidase (DAO) and D-lactate, were measured using corresponding ELISA kits (Enzyme-linked Biotechnology Co. Ltd.) following the provided instructions.</p>
</sec>
<sec id="s2_3">
<label>2.3</label>
<title>Paraffin section preparation and H&amp;E staining</title>
<p>Tissue samples from the heart, liver, spleen, lung, kidney, duodenum, jejunum, ileum, cecum, and colon were collected. Solid organs were trimmed into approximately 1.5 cm &#xd7; 1.5 cm &#xd7; 0.5 cm blocks, and intestinal segments were cut to 2 cm in length. All tissues were rinsed with sterile phosphate-buffered saline (PBS, Solarbio), fixed in 4% neutral buffered formalin (Solarbio) for over 24 hours, and processed for paraffin embedding.</p>
<p>The fixed tissues were dehydrated through a graded ethanol series, cleared in xylene (Sinopharm Chemical Reagent Co., Ltd.), embedded in paraffin (Solarbio), and sectioned at 5 &#x3bc;m thickness. Sections were stained with hematoxylin and eosin (H&amp;E) using a commercial kit (Solarbio) and observed under a light microscope (Leica Microsystems, Wetzlar, Germany). Images were captured using Leica Application Suite X software (version 3.7.4).</p>
</sec>
<sec id="s2_4">
<label>2.4</label>
<title>Immunofluorescence assay</title>
<p>For IFA, deparaffinized and rehydrated sections underwent antigen retrieval by microwave heating in 0.01 M sodium citrate buffer (pH 6.0; Servicebio). Non-specific binding was blocked with 10% goat serum (Solarbio) for 1 h at room temperature. Sections were incubated overnight at 4&#xb0;C with a rabbit polyclonal anti-<italic>G. parasuis</italic> primary antibody (produced in-house by immunizing rabbits with whole-cell antigens of strain XX0306; diluted 1:500). Following three washes, sections were incubated for 45 minutes at 37&#xb0;C with a FITC-conjugated goat anti-rabbit IgG secondary antibody (Epizyme, Shanghai, China; diluted 1:200). For effusion samples (pleural, pericardial, and joint fluid), smears were prepared on glass slides, flame-fixed, and processed identically from the blocking step onward. Slides were mounted with 90% glycerol in PBS and visualized under a fluorescence microscope (Leica Microsystems).</p>
</sec>
<sec id="s2_5">
<label>2.5</label>
<title>Sample collection for microbiome and metabolome analyses</title>
<p>Alveolar lavage fluid (ALF): The entire lung was excised, and bronchoalveolar lavage was performed by instilling and gently kneading with 50 mL of ice-cold sterile PBS. The recovered lavage fluid was centrifuged at 8,000 rpm for 10 min at 4&#xb0;C. The pellet was snap-frozen in liquid nitrogen and stored at -80&#xb0;C for subsequent DNA extraction.</p>
<p>Cecal contents: The cecum was exteriorized, and a segment was ligated at both ends. The outer surface was disinfected with 75% ethanol and rinsed with PBS. The segment was opened aseptically, and the luminal contents were collected using a sterile scalpel, placed into 2 mL cryovials, snap-frozen in liquid nitrogen, and stored at -80&#xb0;C.</p>
</sec>
<sec id="s2_6">
<label>2.6</label>
<title>16S rRNA gene sequencing and analysis</title>
<p>Microbial DNA was extracted from ALF pellets and cecal contents using the HiPure Stool DNA Kit (Magen, Guangzhou, China) according to the manufacturer&#x2019;s protocol. The V3-V4 hypervariable region of the bacterial 16S rRNA gene was amplified with universal primers (341F: CCTACGGGNGGCWGCAG-3&#x2019;; 806R: GGACTACHVGGGTATCTAAT-5&#x2019;). Amplicons were purified, quantified, and sequenced on an Illumina NovaSeq 6000 platform (PE250) by GeneDenovo Biotechnology Co., Ltd. (Guangzhou, China).</p>
<p>Raw sequencing reads were processed using USEARCH (Version 11.0). After merging, quality filtering, and chimera removal, sequences were clustered into operational taxonomic units (OTUs) at 97% similarity. Taxonomic annotation was performed against the SILVA database (Release 138). Microbial community analysis and identification of differential taxa were performed using the LEfSe method (LDA score &gt; 2.0, P &lt; 0.05). Functional potential was predicted from the 16S data using the Tax4Fun2 package in R (based on KEGG database).</p>
</sec>
<sec id="s2_7">
<label>2.7</label>
<title>Metabolite extraction and untargeted metabolomics</title>
<p>Metabolites were extracted from cecal content samples by homogenization in 80% methanol-water solution, followed by sonication in an ice-water bath for 6 minutes and centrifugation at 5,000 rpm for 1 minute at 4&#xb0;C. The supernatant was collected, lyophilized, and reconstituted in 10% methanol. Quality control (QC) samples were prepared by pooling equal volumes from all samples.</p>
<p>Untargeted metabolomic profiling was performed by GeneDenovo Biotechnology Co., Ltd. Specifically, analysis was conducted using ultra-high-performance liquid chromatography coupled with quadrupole-Exactive mass spectrometry (UHPLC-QE-MS) on a Thermo Fisher Vanquish UHPLC system equipped with a Q Exactive HF-X mass spectrometer (Thermo Fisher Scientific, Waltham, MA, USA). Chromatographic separation was achieved on a Hypersil Gold C18 column (100 &#xd7; 2.1 mm, 1.9 &#x3bc;m; Thermo Fisher Scientific) at 40 &#xb0;C using a methanol/water gradient in both positive (0.1% formic acid) and negative (5 mM ammonium acetate) ionization modes. Full MS scans ranged from m/z 100 to 1,500. Raw data were processed using Compound Discoverer software (Version 3.3; Thermo Fisher Scientific). Orthogonal partial least squares-discriminant analysis (OPLS-DA) was performed using the ropls package, and the model was validated by permutation tests. Differential metabolites were identified based on a variable importance in projection (VIP) &#x2265; 1 and a Student&#x2019;s t-test p-value &lt; 0.05. Metabolite annotation and pathway enrichment analysis were conducted using the KEGG database (<ext-link ext-link-type="uri" xlink:href="https://www.genome.jp/kegg">https://www.genome.jp/kegg</ext-link>).</p>
</sec>
<sec id="s2_8">
<label>2.8</label>
<title>Correlation analysis between microbiota and metabolites</title>
<p>Correlations between the relative abundance of differentially abundant intestinal microbial genera and the intensity of differential metabolites were assessed using Pearson&#x2019;s correlation coefficient, calculated with the cor.test function in R (Version 4.3.1).</p>
</sec>
<sec id="s2_9">
<label>2.9</label>
<title>Statistical analysis</title>
<p>Data are presented as mean &#xb1; standard deviation (SD). Statistical analysis and visualization were conducted using SPSS 15.0 software (SPSS Inc., Chicago, IL, USA) and GraphPad Prism 8.0 software (GraphPad Software, San Diego, CA, USA). Comparisons between two groups were made using an independent samples t-test, with a significance level set at P &lt; 0.05, indicating a statistically significant difference.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<label>3</label>
<title>Results</title>
<sec id="s3_1">
<label>3.1</label>
<title>Clinical signs, gross pathology, and pathogen detection following <italic>G. parasuis</italic> infection</title>
<p>Piglets inoculated with <italic>Glaesserella parasuis</italic> strain XX0306 developed clinical signs including growth retardation, coughing, and joint swelling (<xref ref-type="fig" rid="f1"><bold>Figure&#xa0;1A</bold></xref>). At necropsy, infected piglets exhibited characteristic lesions of Gl&#xe4;sser&#x2019;s disease: fibrinous polyserositis manifesting as pleural and pericardial effusions with velvet heart appearance, hepatic congestion, and pulmonary consolidation with surface hemorrhages (<xref ref-type="fig" rid="f1"><bold>Figures&#xa0;1B, C</bold></xref>). Histopathological analysis confirmed myocardial fiber disruption, alveolar congestion, and extensive inflammatory cell infiltration in the lungs (<xref ref-type="fig" rid="f1"><bold>Figure&#xa0;1D</bold></xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Clinical signs and pathological lesions in piglets caused by infection with <italic>G</italic>. <italic>parasuis</italic>. <bold>(A)</bold> Hind limb swelling in piglets from the infected group. <bold>(B)</bold> Thoracic and pericardial effusions observed in the infected group. I: Pleural effusion; II: Pericardial effusion. <bold>(C)</bold> Pictures of the changes in the dissection of organ. Note: &#x2190;: Fibrous exudate; <inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-16-1740531-i001.tif"><alt-text content-type="machine-generated">Panel A shows a pig with areas marked in red, indicating visible changes. Panel B shows close-up images of tissue with arrows pointing to lesions. Panel C compares organs from control and infected pigs, highlighting differences with black arrows. Panel D presents histological images of heart, liver, spleen, lungs, and kidney tissues from control and infected pigs, showing cellular changes marked by arrows or other symbols.</alt-text></inline-graphic>: Hemorrhage. <bold>(D)</bold> Pictures of each organ section of piglets(400X). Note: a, c, e, g, and i correspond to the heart, liver, spleen, lungs, and kidneys in the control group; b, d, f, h, and j correspond to the heart, liver, spleen, lungs, and kidneys in the infected group, respectively; <inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-16-1740531-i002.tif"><alt-text content-type="machine-generated">Panel A shows a pig with areas marked in red, indicating visible changes. Panel B shows close-up images of tissue with arrows pointing to lesions. Panel C compares organs from control and infected pigs, highlighting differences with black arrows. Panel D presents histological images of heart, liver, spleen, lungs, and kidney tissues from control and infected pigs, showing cellular changes marked by arrows or other symbols.</alt-text></inline-graphic>: Hyperemia; <inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-16-1740531-i003.tif"><alt-text content-type="machine-generated">Panel A shows a pig with areas marked in red, indicating visible changes. Panel B shows close-up images of tissue with arrows pointing to lesions. Panel C compares organs from control and infected pigs, highlighting differences with black arrows. Panel D presents histological images of heart, liver, spleen, lungs, and kidney tissues from control and infected pigs, showing cellular changes marked by arrows or other symbols.</alt-text></inline-graphic>: Hemorrhage; <inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-16-1740531-i004.tif"><alt-text content-type="machine-generated">Panel A shows a pig with areas marked in red, indicating visible changes. Panel B shows close-up images of tissue with arrows pointing to lesions. Panel C compares organs from control and infected pigs, highlighting differences with black arrows. Panel D presents histological images of heart, liver, spleen, lungs, and kidney tissues from control and infected pigs, showing cellular changes marked by arrows or other symbols.</alt-text></inline-graphic>: Infiltration of inflammatory cells; <inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-16-1740531-i005.tif"><alt-text content-type="machine-generated">Panel A shows a pig with areas marked in red, indicating visible changes. Panel B shows close-up images of tissue with arrows pointing to lesions. Panel C compares organs from control and infected pigs, highlighting differences with black arrows. Panel D presents histological images of heart, liver, spleen, lungs, and kidney tissues from control and infected pigs, showing cellular changes marked by arrows or other symbols.</alt-text></inline-graphic>: Particle deformation; <inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-16-1740531-i006.tif"><alt-text content-type="machine-generated">Panel A shows a pig with areas marked in red, indicating visible changes. Panel B shows close-up images of tissue with arrows pointing to lesions. Panel C compares organs from control and infected pigs, highlighting differences with black arrows. Panel D presents histological images of heart, liver, spleen, lungs, and kidney tissues from control and infected pigs, showing cellular changes marked by arrows or other symbols.</alt-text></inline-graphic>: Nuclear lysis; <inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-16-1740531-i007.tif"><alt-text content-type="machine-generated">Panel A shows a pig with areas marked in red, indicating visible changes. Panel B shows close-up images of tissue with arrows pointing to lesions. Panel C compares organs from control and infected pigs, highlighting differences with black arrows. Panel D presents histological images of heart, liver, spleen, lungs, and kidney tissues from control and infected pigs, showing cellular changes marked by arrows or other symbols.</alt-text></inline-graphic>: Nuclear condensation. Heart: In the infected group (1-E-b), myocardial fibers exhibited fragmentation and disorganized arrangement, accompanied by granular degeneration and extensive inflammatory cell infiltration. Liver: In the infected group (1-E-d), hepatocytes were disorganized, sinusoids were obliterated, and central venous congestion was observed. Hepatocytes appeared swollen and rounded, with granular degeneration and nuclear dissolution. Spleen: In the infected group (1-E-f), splenic tissue showed hemorrhage, widespread distribution of red blood cells, and significant inflammatory cell infiltration. Lung: In the infected group (1-E-h), alveolar walls were dilated and congested, with extensive inflammatory cell infiltration and loss of alveolar structure. Kidney: In the infected group (1-E-j), nuclear dissolution and congestion were observed, along with swelling and rupture of renal tubules.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-16-1740531-g001.tif">
<alt-text content-type="machine-generated">Panel A shows a pig with areas marked in red, indicating visible changes. Panel B shows close-up images of tissue with arrows pointing to lesions. Panel C compares organs from control and infected pigs, highlighting differences with black arrows. Panel D presents histological images of heart, liver, spleen, lungs, and kidney tissues from control and infected pigs, showing cellular changes marked by arrows or other symbols. Panel A shows a pig with areas marked in red, indicating visible changes. Panel B shows close-up images of tissue with arrows pointing to lesions. Panel C compares organs from control and infected pigs, highlighting differences with black arrows. Panel D presents histological images of heart, liver, spleen, lungs, and kidney tissues from control and infected pigs, showing cellular changes marked by arrows or other symbols. Panel A shows a pig with areas marked in red, indicating visible changes. Panel B shows close-up images of tissue with arrows pointing to lesions. Panel C compares organs from control and infected pigs, highlighting differences with black arrows. Panel D presents histological images of heart, liver, spleen, lungs, and kidney tissues from control and infected pigs, showing cellular changes marked by arrows or other symbols. Panel A shows a pig with areas marked in red, indicating visible changes. Panel B shows close-up images of tissue with arrows pointing to lesions. Panel C compares organs from control and infected pigs, highlighting differences with black arrows. Panel D presents histological images of heart, liver, spleen, lungs, and kidney tissues from control and infected pigs, showing cellular changes marked by arrows or other symbols. Panel A shows a pig with areas marked in red, indicating visible changes. Panel B shows close-up images of tissue with arrows pointing to lesions. Panel C compares organs from control and infected pigs, highlighting differences with black arrows. Panel D presents histological images of heart, liver, spleen, lungs, and kidney tissues from control and infected pigs, showing cellular changes marked by arrows or other symbols. Panel A shows a pig with areas marked in red, indicating visible changes. Panel B shows close-up images of tissue with arrows pointing to lesions. Panel C compares organs from control and infected pigs, highlighting differences with black arrows. Panel D presents histological images of heart, liver, spleen, lungs, and kidney tissues from control and infected pigs, showing cellular changes marked by arrows or other symbols. Panel A shows a pig with areas marked in red, indicating visible changes. Panel B shows close-up images of tissue with arrows pointing to lesions. Panel C compares organs from control and infected pigs, highlighting differences with black arrows. Panel D presents histological images of heart, liver, spleen, lungs, and kidney tissues from control and infected pigs, showing cellular changes marked by arrows or other symbols. Panel A shows a pig with areas marked in red, indicating visible changes. Panel B shows close-up images of tissue with arrows pointing to lesions. Panel C compares organs from control and infected pigs, highlighting differences with black arrows. Panel D presents histological images of heart, liver, spleen, lungs, and kidney tissues from control and infected pigs, showing cellular changes marked by arrows or other symbols.</alt-text>
</graphic></fig>
<p>Consistent with the observed pathology, serum levels of pro-inflammatory cytokines (TNF-&#x3b1;, IL-1&#x3b2;, and IL-8) were significantly elevated in the infected group compared to the uninfected control group (<xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2A</bold></xref>). Immunofluorescence assay (IFA) directly detected the presence of <italic>G. parasuis</italic> in pleural effusions, pericardial effusions, and lung tissues of infected piglets (<xref ref-type="fig" rid="f2"><bold>Figures&#xa0;2B, C</bold></xref>). In contrast, <italic>G. parasuis</italic> was not detected by IFA in joint effusions from the same animals.</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Levels of inflammatory cytokines in piglet serum and <italic>in vivo</italic> localization of <italic>G. parasuis</italic>. <bold>(A)</bold> Changes in the concentration of inflammatory factors in the serum.&#x201d;*&#x201d; P &lt; 0.05, &#x201c;**&#x201d; P &lt; 0.01. <bold>(B)</bold> Indirect immunofluorescence results. Note: a, d, g: indicate spontaneous fluorescence control for pleural effusion, joint effusion and pericardial effusion specimens, respectively; b, e, h: indicate pleural effusion, joint effusion and pericardial effusion fluorescent antibody control groups, respectively; c, f, i: indicate pleural effusion, joint effusion and pericardial effusion infected groups for pleural effusion fluorescence staining, respectively; Microscope magnification of 400&#xd7;. <bold>(C)</bold> Immunofluorescence results of lung tissue. a, in the control group; b, is in the infected group; 1, Account field; 2, Specimen autofluorescence control; 3, Fluorescent antibody control; 4, Control lung; Microscope magnification of 400&#xd7;.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-16-1740531-g002.tif">
<alt-text content-type="machine-generated">Panel A shows a bar graph comparing serum factor concentrations, with significant differences between control and infected groups for IL-8, IL-1&#x3b2;, and TNF-&#x3b1;. Panel B displays a series of fluorescence microscopy images labeled a to i, showing varying intensities of brightness. Panel C includes light microscopy images labeled a1 to b4, with differences in cell morphology and fluorescence, including a highlighted area in b4 with a red arrow.</alt-text>
</graphic></fig>
</sec>
<sec id="s3_2">
<label>3.2</label>
<title><italic>G. parasuis</italic> infection alters the composition and function of the lung microbiota</title>
<p>The composition of the lung microbiota was characterized using 16S rRNA gene sequencing. A total of 1,622 operational taxonomic units (OTUs) were identified, with 340 OTUs shared between the infected and uninfected groups (<xref ref-type="fig" rid="f3"><bold>Figure&#xa0;3A</bold></xref>). Alpha diversity indices (Shannon, Simpson, and Pielou) were significantly lower in infected piglets, confirming a reduction in lung microbial diversity post-infection (<xref ref-type="fig" rid="f3"><bold>Figure&#xa0;3B</bold></xref>). Beta diversity analysis (ANOSIM, R = 0.117) suggested a separation between groups, although this did not reach statistical significance (P = 0.106) (<xref ref-type="fig" rid="f3"><bold>Figure&#xa0;3C</bold></xref>).</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Lung microbiome profiling. <bold>(A)</bold> Number of OTU Venn diagram. <bold>(B)</bold> Alpha diversity analysis. &#x201c;*&#x201d; P &lt; 0.05 indicates a significant difference between the infected group and the control group. <bold>(C)</bold> Beta Diversity analysis. a, PCoA scatter plot; b, ANOSIM box line plot. <bold>(D)</bold> Column stacking of relative abundance of lung flora. <bold>(E)</bold> Differential species analysis. a, Venn diagram of species at the genus level; b, LEfSe marker species analysis. <bold>(F)</bold> KEGG T-test difference histogram.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-16-1740531-g003.tif">
<alt-text content-type="machine-generated">Diagram displaying multiple panels:  (A) Venn diagram showing shared and unique features between control and infected groups.   (B) Bar graphs illustrating diversity indices (Shannon, Simpson, Pielou) for control and infected, with significant differences marked.   (C) Principal Component Analysis plot and box plot showing distribution of samples between control and infected groups.   (D) Stacked bar charts presenting relative abundance of microbial communities at phylum, class, order, family, and genus levels.   (E) Venn diagram comparing bacterial taxa between control and infected groups.   (F) Comparative bar graph and plot on functional transport and catabolism differences with confidence intervals, and LDA score bar graph.</alt-text>
</graphic></fig>
<p>At the phylum level, infection led to an increase in the relative abundance of Proteobacteria and slight decreases in Firmicutes, Cyanobacteria, and Bacteroidota (<xref ref-type="table" rid="T1"><bold>Table&#xa0;1</bold></xref>). At the genus level, significant increases in the relative abundances of <italic>Actinobacillus</italic> and <italic>Glaesserella</italic> were observed in infected lungs (<xref ref-type="fig" rid="f3"><bold>Figure&#xa0;3D</bold></xref>). Concurrently, the number of detectable genera was reduced post-infection. The genus <italic>Sandarakinorhabdus</italic> was markedly enriched in the lungs of uninfected piglets (<xref ref-type="fig" rid="f3"><bold>Figure&#xa0;3E</bold></xref>).</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Table of relative abundance of the pulmonary portal level flora.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="center">Group</th>
<th valign="middle" align="center">Proteobacteria</th>
<th valign="middle" align="center">Firmicutes</th>
<th valign="middle" align="center">Cyanobacteria</th>
<th valign="middle" align="center">Bacteroidetes</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="center">Control</td>
<td valign="middle" align="center">56.77%</td>
<td valign="middle" align="center">9.62%</td>
<td valign="middle" align="center">11.05%</td>
<td valign="middle" align="center">9.91%</td>
</tr>
<tr>
<td valign="middle" align="center">Infected</td>
<td valign="middle" align="center">73.93%</td>
<td valign="middle" align="center">8.21%</td>
<td valign="middle" align="center">3.89%</td>
<td valign="middle" align="center">4.27%</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>&#x201c;*&#x201d; P &lt; 0.05 indicates significant difference between the infected group and the control group.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>Functional prediction based on 16S data revealed that the abundance of genes associated with microbial transport and catabolism was significantly lower in the lung microbiota of infected piglets (<xref ref-type="fig" rid="f3"><bold>Figure&#xa0;3F</bold></xref>).</p>
</sec>
<sec id="s3_3">
<label>3.3</label>
<title><italic>G. parasuis</italic> infection alters gut microbial diversity, composition, and function</title>
<p>Analysis of 16S rRNA gene sequencing data revealed a total of 1,025 OTUs in cecal contents, with 398 OTUs shared between infected and uninfected piglets (<xref ref-type="fig" rid="f4"><bold>Figure&#xa0;4A</bold></xref>). Alpha diversity indices (Chao and ACE) showed an increasing trend in infected piglets, indicating elevated microbial richness, though these changes were not statistically significant. Goods coverage values confirmed sufficient sequencing depth. Beta diversity analysis (PCoA) revealed distinct clustering between groups, which was supported by a significant ANOSIM result (R = 0.356, P&lt;0.01) (<xref ref-type="fig" rid="f4"><bold>Figures&#xa0;4B, C</bold></xref>).</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Intestinal microbiome profiling. <bold>(A)</bold> OTU Venn diagram. <bold>(B)</bold> Venn diagram of species at the genus level. <bold>(C)</bold> Beta Diversity analysis results. a, PCoA scatter plot; b, ANOSIM box line plot. <bold>(D)</bold> Column stacking diagram of relative abundance of intestinal flora. <bold>(E)</bold> Enriched gut microbiota at the genus level (LDA&gt;2, P &lt; 0.05). <bold>(F)</bold> KEGG T test difference histogram.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-16-1740531-g004.tif">
<alt-text content-type="machine-generated">The image depicts multiple panels analyzing microbial data. Panel A and B show Venn diagrams comparing control and infected groups, highlighting common and unique datasets. Panel C includes a PCA plot and boxplots showing variation between groups. Panel D displays bar graphs of relative abundance at phylum, class, order, and family levels, detailing microbial composition. Panel E features a bar graph of LDA scores illustrating significant taxa differences. Panel F presents graphs on metabolic pathway analysis, showing mean abundance and differences with significance levels. Control and infected groups are color-coded for comparison across panels.</alt-text>
</graphic></fig>
<p>At the phylum level, the gut microbiota was dominated by Firmicutes, Bacteroidota, Proteobacteria, and Actinobacteria. Infection led to a significant decrease in the relative abundance of Firmicutes (uninfected: 84.41%; infected: 76.10%) and Bacteroidota (9.22% to 3.93%), accompanied by an increase in Proteobacteria (2.40% to 9.08%) and Actinobacteria (2.98% to 4.54%) (<xref ref-type="fig" rid="f4"><bold>Figure&#xa0;4D</bold></xref>; <xref ref-type="table" rid="T2"><bold>Table&#xa0;2</bold></xref>).</p>
<table-wrap id="T2" position="float">
<label>Table&#xa0;2</label>
<caption>
<p>Table of relative abundance of intestinal facultative level flora.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="center">Group</th>
<th valign="middle" align="center">Firmicutes</th>
<th valign="middle" align="center">Bacteroidetes</th>
<th valign="middle" align="center">Proteobacteria</th>
<th valign="middle" align="center">Actinobacteria</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="center">Control</td>
<td valign="middle" align="center">84.41%</td>
<td valign="middle" align="center">9.22%</td>
<td valign="middle" align="center">2.40%</td>
<td valign="middle" align="center">2.98%</td>
</tr>
<tr>
<td valign="middle" align="center">Infected</td>
<td valign="middle" align="center">76.10%</td>
<td valign="middle" align="center">3.93%</td>
<td valign="middle" align="center">9.08%</td>
<td valign="middle" align="center">4.54%</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>LEfSe analysis (LDA &gt; 2, P&lt;0.05) identified a pronounced dysbiosis at the genus level, characterized by a marked increase in potentially pathogenic genera and a concurrent decrease in several beneficial taxa. Specifically, infected piglets showed a significant increase (P&lt;0.01) in the relative abundances of <italic>Streptococcus</italic>, <italic>Campylobacter</italic>, and <italic>Desulfovibrio</italic> genera, which are often associated with intestinal inflammation or dysfunction. In contrast, the abundances of beneficial genera such as <italic>Prevotella_9</italic> and <italic>Lachnospira</italic>, which are involved in fiber fermentation and short-chain fatty acid production, were significantly reduced (P&lt;0.05). Interestingly, the abundance of another beneficial genus, <italic>Bifidobacterium</italic>, was significantly higher in the infected group (P&lt;0.01) (<xref ref-type="fig" rid="f4"><bold>Figure&#xa0;4E</bold></xref>; <xref ref-type="table" rid="T3"><bold>Table&#xa0;3</bold></xref>).</p>
<table-wrap id="T3" position="float">
<label>Table&#xa0;3</label>
<caption>
<p>Species significantly enriched at the genus level in intestinal flora.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="center">Genus</th>
<th valign="middle" align="center">Group</th>
<th valign="middle" align="center">LDA score</th>
<th valign="middle" align="center">P value</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="center">Catenisphaera</td>
<td valign="middle" align="center">Control</td>
<td valign="middle" align="center">4.7620</td>
<td valign="middle" align="center">0.0039</td>
</tr>
<tr>
<td valign="middle" align="center">Prevotella_9</td>
<td valign="middle" align="center">Control</td>
<td valign="middle" align="center">4.3950</td>
<td valign="middle" align="center">0.0039</td>
</tr>
<tr>
<td valign="middle" align="center">Lachnospira</td>
<td valign="middle" align="center">Control</td>
<td valign="middle" align="center">3.4856</td>
<td valign="middle" align="center">0.0039</td>
</tr>
<tr>
<td valign="middle" align="center">Libanicoccus</td>
<td valign="middle" align="center">Control</td>
<td valign="middle" align="center">3.4838</td>
<td valign="middle" align="center">0.0039</td>
</tr>
<tr>
<td valign="middle" align="center">Prevotella_7</td>
<td valign="middle" align="center">Control</td>
<td valign="middle" align="center">3.3247</td>
<td valign="middle" align="center">0.0039</td>
</tr>
<tr>
<td valign="middle" align="center">Streptococcus</td>
<td valign="middle" align="center">Infected</td>
<td valign="middle" align="center">4.4910</td>
<td valign="middle" align="center">0.0039</td>
</tr>
<tr>
<td valign="middle" align="center">Campylobacter</td>
<td valign="middle" align="center">Infected</td>
<td valign="middle" align="center">4.2357</td>
<td valign="middle" align="center">0.0039</td>
</tr>
<tr>
<td valign="middle" align="center">Bifidobacterium</td>
<td valign="middle" align="center">Infected</td>
<td valign="middle" align="center">3.8901</td>
<td valign="middle" align="center">0.0039</td>
</tr>
<tr>
<td valign="middle" align="center">Veillonella</td>
<td valign="middle" align="center">Infected</td>
<td valign="middle" align="center">3.3485</td>
<td valign="middle" align="center">0.0039</td>
</tr>
<tr>
<td valign="middle" align="center">Lachnospiraceae_XPB1014_group</td>
<td valign="middle" align="center">Infected</td>
<td valign="middle" align="center">3.2651</td>
<td valign="middle" align="center">0.0033</td>
</tr>
<tr>
<td valign="middle" align="center">Desulfovibrio</td>
<td valign="middle" align="center">Infected</td>
<td valign="middle" align="center">3.2036</td>
<td valign="middle" align="center">0.0039</td>
</tr>
<tr>
<td valign="middle" align="center">Weissella</td>
<td valign="middle" align="center">Infected</td>
<td valign="middle" align="center">3.1024</td>
<td valign="middle" align="center">0.0039</td>
</tr>
<tr>
<td valign="middle" align="center">Actinomyces</td>
<td valign="middle" align="center">Infected</td>
<td valign="middle" align="center">2.9996</td>
<td valign="middle" align="center">0.0037</td>
</tr>
<tr>
<td valign="middle" align="center">Leucobacter</td>
<td valign="middle" align="center">Infected</td>
<td valign="middle" align="center">2.9993</td>
<td valign="middle" align="center">0.0039</td>
</tr>
<tr>
<td valign="middle" align="center">Akkermansia</td>
<td valign="middle" align="center">Infected</td>
<td valign="middle" align="center">2.8167</td>
<td valign="middle" align="center">0.0021</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Functional prediction (Tax4Fun2) indicated significant alterations in 12 KEGG pathways. Pathways for Amino Acid Metabolism, Metabolism of Cofactors and Vitamins, and Cell Growth and Death were significantly downregulated in infected piglets (P&lt;0.01). In contrast, pathways for Carbohydrate Metabolism, Lipid Metabolism, and Xenobiotics Biodegradation and Metabolism were significantly upregulated (P&lt;0.05 or P&lt;0.05) (<xref ref-type="fig" rid="f4"><bold>Figure&#xa0;4F</bold></xref>; <xref ref-type="table" rid="T4"><bold>Table&#xa0;4</bold></xref>).</p>
<table-wrap id="T4" position="float">
<label>Table&#xa0;4</label>
<caption>
<p>The differences in relative abundance of functional genes in gut microbiota in each pathway.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="center">Pathway</th>
<th valign="middle" align="center">Control</th>
<th valign="middle" align="center">Infected</th>
<th valign="middle" align="center">P-value</th>
<th valign="middle" align="center">Change</th>
<th valign="middle" align="center">Significant</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="center">Carbohydrate Metabolism</td>
<td valign="middle" align="center">0.1348</td>
<td valign="middle" align="center">0.1443</td>
<td valign="middle" align="center">0.0017</td>
<td valign="middle" align="center">Up</td>
<td valign="middle" align="center">**</td>
</tr>
<tr>
<td valign="middle" align="center">Amino Acid Metabolism</td>
<td valign="middle" align="center">0.1229</td>
<td valign="middle" align="center">0.1093</td>
<td valign="middle" align="center">0.0031</td>
<td valign="middle" align="center">Down</td>
<td valign="middle" align="center">**</td>
</tr>
<tr>
<td valign="middle" align="center">Metabolism of Cofactors and Vitamins</td>
<td valign="middle" align="center">0.0734</td>
<td valign="middle" align="center">0.0649</td>
<td valign="middle" align="center">0.0072</td>
<td valign="middle" align="center">Down</td>
<td valign="middle" align="center">**</td>
</tr>
<tr>
<td valign="middle" align="center">Lipid Metabolism</td>
<td valign="middle" align="center">0.0294</td>
<td valign="middle" align="center">0.0345</td>
<td valign="middle" align="center">0.0011</td>
<td valign="middle" align="center">Up</td>
<td valign="middle" align="center">**</td>
</tr>
<tr>
<td valign="middle" align="center">Xenobiotics Biodegradation and Metabolism</td>
<td valign="middle" align="center">0.0261</td>
<td valign="middle" align="center">0.0283</td>
<td valign="middle" align="center">0.0014</td>
<td valign="middle" align="center">Up</td>
<td valign="middle" align="center">**</td>
</tr>
<tr>
<td valign="middle" align="center">Metabolism of Other Amino Acids</td>
<td valign="middle" align="center">0.0226</td>
<td valign="middle" align="center">0.0253</td>
<td valign="middle" align="center">0.0017</td>
<td valign="middle" align="center">Up</td>
<td valign="middle" align="center">**</td>
</tr>
<tr>
<td valign="middle" align="center">Infectious Diseases</td>
<td valign="middle" align="center">0.0180</td>
<td valign="middle" align="center">0.0242</td>
<td valign="middle" align="center">0.0180</td>
<td valign="middle" align="center">Up</td>
<td valign="middle" align="center">*</td>
</tr>
<tr>
<td valign="middle" align="center">Metabolism of Terpenoids and Polyketides</td>
<td valign="middle" align="center">0.0182</td>
<td valign="middle" align="center">0.0222</td>
<td valign="middle" align="center">0.0003</td>
<td valign="middle" align="center">Up</td>
<td valign="middle" align="center">**</td>
</tr>
<tr>
<td valign="middle" align="center">Cell Growth and Death</td>
<td valign="middle" align="center">0.0163</td>
<td valign="middle" align="center">0.0134</td>
<td valign="middle" align="center">0.0013</td>
<td valign="middle" align="center">Down</td>
<td valign="middle" align="center">**</td>
</tr>
<tr>
<td valign="middle" align="center">Biosynthesis of Other Secondary Metabolites</td>
<td valign="middle" align="center">0.0076</td>
<td valign="middle" align="center">0.0082</td>
<td valign="middle" align="center">0.0191</td>
<td valign="middle" align="center">Up</td>
<td valign="middle" align="center">*</td>
</tr>
<tr>
<td valign="middle" align="center">Transport and Catabolism</td>
<td valign="middle" align="center">0.0019</td>
<td valign="middle" align="center">0.0022</td>
<td valign="middle" align="center">0.0097</td>
<td valign="middle" align="center">Up</td>
<td valign="middle" align="center">**</td>
</tr>
<tr>
<td valign="middle" align="center">Neurodegenerative Diseases</td>
<td valign="middle" align="center">0.0015</td>
<td valign="middle" align="center">0.0018</td>
<td valign="middle" align="center">0.0056</td>
<td valign="middle" align="center">Up</td>
<td valign="middle" align="center">**</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>&#x201c;*&#x201d; P &lt; 0.05 represents significant differences between two groups. &#x201c;**&#x201d; P &lt; 0.01 represents extremely significant differences between two groups.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3_4">
<label>3.4</label>
<title><italic>G. parasuis</italic> infection perturbs the arginine biosynthesis pathway and alters key metabolites in cecal contents</title>
<p>Untargeted metabolomic analysis of cecal contents using both positive and negative ionization modes showed clear separation between infected and uninfected piglets in the OPLS-DA score plots, with robust model validation (<xref ref-type="fig" rid="f5"><bold>Figures&#xa0;5A&#x2013;C</bold></xref>).</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Intestinal content metabolite profiling. <bold>(A)</bold> Principal component analysis of QC samples. <bold>(B)</bold> OPLS-DA score graph. <bold>(C)</bold> OPLS-DA substitution test. <bold>(D)</bold> Volcano map of differential metabolites. In <bold>(A&#x2013;D)</bold>, the left diagram is in positive ion mode, and the right diagram is in negative ion mode. <bold>(E)</bold> The top 20 metabolic pathways KEGG enrichment. The vertical coordinate is the pathway and the horizontal coordinate is the enrichment factor, which is the proportion of differential metabolites in that pathway to the total metabolites in that pathway.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-16-1740531-g005.tif">
<alt-text content-type="machine-generated">Graphs display Principal Component Analysis (PCA) with distinct grouping, orthogonal projections, and validation scores. Volcano plots assess significance with colored markers for upregulation, downregulation, and no difference. KEGG enrichment bubble chart shows top 20 pathways, correlating rich factor with metabolite numbers, where bubble size indicates quantity.</alt-text>
</graphic></fig>
<p>A total of 119 differential metabolites were identified (VIP &#x2265; 1, P&lt;0.05). Among these, 30 metabolites (22 in positive and 8 in negative mode) were successfully annotated in the KEGG database (<xref ref-type="fig" rid="f5"><bold>Figure&#xa0;5D</bold></xref>). Fifteen metabolites, including liquiritigenin (P&lt;0.01), citraconic acid (P&lt;0.05), and argininosuccinic acid (P&lt;0.05), were significantly decreased in infected piglets. Conversely, fifteen metabolites, including citrulline (P&lt;0.01) and N-acetyl-L-phenylalanine (P&lt;0.05), were significantly increased (<xref ref-type="table" rid="T5"><bold>Table&#xa0;5</bold></xref>).</p>
<table-wrap id="T5" position="float">
<label>Table&#xa0;5</label>
<caption>
<p>Information related to differential metabolites.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="center">Name</th>
<th valign="middle" align="center">Formula</th>
<th valign="middle" align="center">P value</th>
<th valign="middle" align="center">Vip</th>
<th valign="middle" align="center">Mode</th>
<th valign="middle" align="center">Group</th>
<th valign="middle" align="center">C_ID</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="center">Liquiritigenin</td>
<td valign="middle" align="center">C15H12O4</td>
<td valign="middle" align="center">0.0002</td>
<td valign="middle" align="center">2.5310</td>
<td valign="middle" align="center">NEG</td>
<td valign="middle" align="center">Control</td>
<td valign="middle" align="center">C09762</td>
</tr>
<tr>
<td valign="middle" align="center">Citraconic acid</td>
<td valign="middle" align="center">C5H6O4</td>
<td valign="middle" align="center">0.0172</td>
<td valign="middle" align="center">2.0149</td>
<td valign="middle" align="center">NEG</td>
<td valign="middle" align="center">Control</td>
<td valign="middle" align="center">C02226</td>
</tr>
<tr>
<td valign="middle" align="center">Cyclamic acid</td>
<td valign="middle" align="center">C6H13NO3S</td>
<td valign="middle" align="center">0.0197</td>
<td valign="middle" align="center">1.9342</td>
<td valign="middle" align="center">NEG</td>
<td valign="middle" align="center">Control</td>
<td valign="middle" align="center">C02824</td>
</tr>
<tr>
<td valign="middle" align="center">Capric acid</td>
<td valign="middle" align="center">C10H20O2</td>
<td valign="middle" align="center">0.0235</td>
<td valign="middle" align="center">1.8459</td>
<td valign="middle" align="center">NEG</td>
<td valign="middle" align="center">Control</td>
<td valign="middle" align="center">C01571</td>
</tr>
<tr>
<td valign="middle" align="center">Taurine</td>
<td valign="middle" align="center">C2H7NO3S</td>
<td valign="middle" align="center">0.0438</td>
<td valign="middle" align="center">1.6398</td>
<td valign="middle" align="center">NEG</td>
<td valign="middle" align="center">Control</td>
<td valign="middle" align="center">C00245</td>
</tr>
<tr>
<td valign="middle" align="center">Ergocalciferol</td>
<td valign="middle" align="center">C28H44O</td>
<td valign="middle" align="center">0.0037</td>
<td valign="middle" align="center">1.9869</td>
<td valign="middle" align="center">POS</td>
<td valign="middle" align="center">Control</td>
<td valign="middle" align="center">C05441</td>
</tr>
<tr>
<td valign="middle" align="center">Argininosuccinic acid</td>
<td valign="middle" align="center">C10H18N4O6</td>
<td valign="middle" align="center">0.0105</td>
<td valign="middle" align="center">1.9459</td>
<td valign="middle" align="center">POS</td>
<td valign="middle" align="center">Control</td>
<td valign="middle" align="center">C03406</td>
</tr>
<tr>
<td valign="middle" align="center">N-Acetylornithine</td>
<td valign="middle" align="center">C7H14N2O3</td>
<td valign="middle" align="center">0.0127</td>
<td valign="middle" align="center">1.9390</td>
<td valign="middle" align="center">POS</td>
<td valign="middle" align="center">Control</td>
<td valign="middle" align="center">C00437</td>
</tr>
<tr>
<td valign="middle" align="center">Riboflavin-5-phosphate</td>
<td valign="middle" align="center">C17H21N4O9P</td>
<td valign="middle" align="center">0.0123</td>
<td valign="middle" align="center">1.9179</td>
<td valign="middle" align="center">POS</td>
<td valign="middle" align="center">Control</td>
<td valign="middle" align="center">C00061</td>
</tr>
<tr>
<td valign="middle" align="center">L-Adrenaline</td>
<td valign="middle" align="center">C9H13NO3</td>
<td valign="middle" align="center">0.0123</td>
<td valign="middle" align="center">1.9175</td>
<td valign="middle" align="center">POS</td>
<td valign="middle" align="center">Control</td>
<td valign="middle" align="center">C00788</td>
</tr>
<tr>
<td valign="middle" align="center">Deoxyguanosine</td>
<td valign="middle" align="center">C10H13N5O4</td>
<td valign="middle" align="center">0.0209</td>
<td valign="middle" align="center">1.8009</td>
<td valign="middle" align="center">POS</td>
<td valign="middle" align="center">Control</td>
<td valign="middle" align="center">C00330</td>
</tr>
<tr>
<td valign="middle" align="center">2-Oxindole</td>
<td valign="middle" align="center">C8H7NO</td>
<td valign="middle" align="center">0.0360</td>
<td valign="middle" align="center">1.7719</td>
<td valign="middle" align="center">POS</td>
<td valign="middle" align="center">Control</td>
<td valign="middle" align="center">C12312</td>
</tr>
<tr>
<td valign="middle" align="center">Pregnenolone</td>
<td valign="middle" align="center">C21H32O2</td>
<td valign="middle" align="center">0.0351</td>
<td valign="middle" align="center">1.6212</td>
<td valign="middle" align="center">POS</td>
<td valign="middle" align="center">Control</td>
<td valign="middle" align="center">C01953</td>
</tr>
<tr>
<td valign="middle" align="center">DL-Panthenol</td>
<td valign="middle" align="center">C9H19NO4</td>
<td valign="middle" align="center">0.0483</td>
<td valign="middle" align="center">1.5356</td>
<td valign="middle" align="center">POS</td>
<td valign="middle" align="center">Control</td>
<td valign="middle" align="center">C05944</td>
</tr>
<tr>
<td valign="middle" align="center">Xanthine</td>
<td valign="middle" align="center">C5H4N4O2</td>
<td valign="middle" align="center">0.0424</td>
<td valign="middle" align="center">1.5057</td>
<td valign="middle" align="center">POS</td>
<td valign="middle" align="center">Control</td>
<td valign="middle" align="center">C00385</td>
</tr>
<tr>
<td valign="middle" align="center">Citrulline</td>
<td valign="middle" align="center">C6H13N3O3</td>
<td valign="middle" align="center">0.0039</td>
<td valign="middle" align="center">2.1641</td>
<td valign="middle" align="center">NEG</td>
<td valign="middle" align="center">Infected</td>
<td valign="middle" align="center">C00327</td>
</tr>
<tr>
<td valign="middle" align="center">N-Acetyl-L-phenylalanine</td>
<td valign="middle" align="center">C11H13NO3</td>
<td valign="middle" align="center">0.0130</td>
<td valign="middle" align="center">2.1529</td>
<td valign="middle" align="center">NEG</td>
<td valign="middle" align="center">Infected</td>
<td valign="middle" align="center">C03519</td>
</tr>
<tr>
<td valign="middle" align="center">Cytidine-5&#x2019;-monophosphate</td>
<td valign="middle" align="center">C9H14N3O8P</td>
<td valign="middle" align="center">0.0434</td>
<td valign="middle" align="center">1.7410</td>
<td valign="middle" align="center">NEG</td>
<td valign="middle" align="center">Infected</td>
<td valign="middle" align="center">C00055</td>
</tr>
<tr>
<td valign="middle" align="center">2-(1H-indol-3-yl) acetic acid</td>
<td valign="middle" align="center">C10H9NO2</td>
<td valign="middle" align="center">0.0041</td>
<td valign="middle" align="center">2.0491</td>
<td valign="middle" align="center">POS</td>
<td valign="middle" align="center">Infected</td>
<td valign="middle" align="center">C00954</td>
</tr>
<tr>
<td valign="middle" align="center">4-Methyl-5-thiazoleethanol</td>
<td valign="middle" align="center">C6H9NOS</td>
<td valign="middle" align="center">0.0152</td>
<td valign="middle" align="center">1.9502</td>
<td valign="middle" align="center">POS</td>
<td valign="middle" align="center">Infected</td>
<td valign="middle" align="center">C04294</td>
</tr>
<tr>
<td valign="middle" align="center">Indole-5,6-quinone</td>
<td valign="middle" align="center">C8H5NO2</td>
<td valign="middle" align="center">0.0155</td>
<td valign="middle" align="center">1.9205</td>
<td valign="middle" align="center">POS</td>
<td valign="middle" align="center">Infected</td>
<td valign="middle" align="center">C05579</td>
</tr>
<tr>
<td valign="middle" align="center">3-Succinoylpyridine</td>
<td valign="middle" align="center">C9H9NO3</td>
<td valign="middle" align="center">0.0401</td>
<td valign="middle" align="center">1.7644</td>
<td valign="middle" align="center">POS</td>
<td valign="middle" align="center">Infected</td>
<td valign="middle" align="center">C19569</td>
</tr>
<tr>
<td valign="middle" align="center">4-Guanidinobutanoic acid</td>
<td valign="middle" align="center">C5H11N3O2</td>
<td valign="middle" align="center">0.0443</td>
<td valign="middle" align="center">1.7067</td>
<td valign="middle" align="center">POS</td>
<td valign="middle" align="center">Infected</td>
<td valign="middle" align="center">C01035</td>
</tr>
<tr>
<td valign="middle" align="center">Dopaquinone</td>
<td valign="middle" align="center">C9H9NO4</td>
<td valign="middle" align="center">0.0244</td>
<td valign="middle" align="center">1.6917</td>
<td valign="middle" align="center">POS</td>
<td valign="middle" align="center">Infected</td>
<td valign="middle" align="center">C00822</td>
</tr>
<tr>
<td valign="middle" align="center">D-Raffinose</td>
<td valign="middle" align="center">C18H32O16</td>
<td valign="middle" align="center">0.0316</td>
<td valign="middle" align="center">1.6906</td>
<td valign="middle" align="center">POS</td>
<td valign="middle" align="center">Infected</td>
<td valign="middle" align="center">C00492</td>
</tr>
<tr>
<td valign="middle" align="center">Carnosine</td>
<td valign="middle" align="center">C9H14N4O3</td>
<td valign="middle" align="center">0.0339</td>
<td valign="middle" align="center">1.6742</td>
<td valign="middle" align="center">POS</td>
<td valign="middle" align="center">Infected</td>
<td valign="middle" align="center">C00386</td>
</tr>
<tr>
<td valign="middle" align="center">Jasmonic acid</td>
<td valign="middle" align="center">C12H18O3</td>
<td valign="middle" align="center">0.0326</td>
<td valign="middle" align="center">1.5927</td>
<td valign="middle" align="center">POS</td>
<td valign="middle" align="center">Infected</td>
<td valign="middle" align="center">C08491</td>
</tr>
<tr>
<td valign="middle" align="center">2-Aminobenzen-Esulfonic acid</td>
<td valign="middle" align="center">C6H7NO3S</td>
<td valign="middle" align="center">0.0407</td>
<td valign="middle" align="center">1.5328</td>
<td valign="middle" align="center">POS</td>
<td valign="middle" align="center">Infected</td>
<td valign="middle" align="center">C06333</td>
</tr>
<tr>
<td valign="middle" align="center">2-Naphthol</td>
<td valign="middle" align="center">C10H8O</td>
<td valign="middle" align="center">0.0458</td>
<td valign="middle" align="center">1.4601</td>
<td valign="middle" align="center">POS</td>
<td valign="middle" align="center">Infected</td>
<td valign="middle" align="center">C11713</td>
</tr>
<tr>
<td valign="middle" align="center">Choline</td>
<td valign="middle" align="center">C5H13NO</td>
<td valign="middle" align="center">0.0467</td>
<td valign="middle" align="center">1.4249</td>
<td valign="middle" align="center">POS</td>
<td valign="middle" align="center">Infected</td>
<td valign="middle" align="center">C00114</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>POS is in positive ion mode, NEG is in negative ion mode.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>KEGG pathway enrichment analysis of the 30 annotated differential metabolites revealed significant alterations in specific metabolic pathways. The top 20 most enriched pathways are listed in <xref ref-type="table" rid="T6"><bold>Table&#xa0;6</bold></xref>, with Metabolism of xenobiotics by cytochrome P450 and Arginine biosynthesis showing the most significant enrichment (both P&lt;0.05, <xref ref-type="fig" rid="f5"><bold>Figure&#xa0;5E</bold></xref>). Notably, three key intermediates of the arginine biosynthesis pathway (argininosuccinate, N-acetylornithine, and citrulline) were identified among the differential metabolites.</p>
<table-wrap id="T6" position="float">
<label>Table&#xa0;6</label>
<caption>
<p>Differential metabolic pathways.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="center">KEGG pathway</th>
<th valign="middle" align="center">P value</th>
<th valign="middle" align="center">Q-value</th>
<th valign="middle" align="center">Pathway ID</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="center">Metabolism of xenobiotics by cytochrome P450</td>
<td valign="middle" align="center">0.020448</td>
<td valign="middle" align="center">0.746202</td>
<td valign="middle" align="center">ko00980</td>
</tr>
<tr>
<td valign="middle" align="center">Arginine biosynthesis</td>
<td valign="middle" align="center">0.045935</td>
<td valign="middle" align="center">0.746202</td>
<td valign="middle" align="center">ko00220</td>
</tr>
<tr>
<td valign="middle" align="center">Chemical carcinogenesis</td>
<td valign="middle" align="center">0.086207</td>
<td valign="middle" align="center">0.746202</td>
<td valign="middle" align="center">ko05204</td>
</tr>
<tr>
<td valign="middle" align="center">Thiamine metabolism</td>
<td valign="middle" align="center">0.165209</td>
<td valign="middle" align="center">0.746202</td>
<td valign="middle" align="center">ko00730</td>
</tr>
<tr>
<td valign="middle" align="center">Sulfur metabolism</td>
<td valign="middle" align="center">0.165209</td>
<td valign="middle" align="center">0.746202</td>
<td valign="middle" align="center">ko00920</td>
</tr>
<tr>
<td valign="middle" align="center">Choline metabolism in cancer</td>
<td valign="middle" align="center">0.165209</td>
<td valign="middle" align="center">0.746202</td>
<td valign="middle" align="center">ko05231</td>
</tr>
<tr>
<td valign="middle" align="center">Oxidative phosphorylation</td>
<td valign="middle" align="center">0.237590</td>
<td valign="middle" align="center">0.746202</td>
<td valign="middle" align="center">ko00190</td>
</tr>
<tr>
<td valign="middle" align="center">Glycerophospholipid metabolism</td>
<td valign="middle" align="center">0.237590</td>
<td valign="middle" align="center">0.746202</td>
<td valign="middle" align="center">ko00564</td>
</tr>
<tr>
<td valign="middle" align="center">alpha-Linolenic acid metabolism</td>
<td valign="middle" align="center">0.237590</td>
<td valign="middle" align="center">0.746202</td>
<td valign="middle" align="center">ko00592</td>
</tr>
<tr>
<td valign="middle" align="center">C5-Branched dibasic acid metabolism</td>
<td valign="middle" align="center">0.237590</td>
<td valign="middle" align="center">0.746202</td>
<td valign="middle" align="center">ko00660</td>
</tr>
<tr>
<td valign="middle" align="center">Cholinergic synapse</td>
<td valign="middle" align="center">0.237590</td>
<td valign="middle" align="center">0.746202</td>
<td valign="middle" align="center">ko04725</td>
</tr>
<tr>
<td valign="middle" align="center">Tyrosine metabolism</td>
<td valign="middle" align="center">0.242523</td>
<td valign="middle" align="center">0.746202</td>
<td valign="middle" align="center">ko00350</td>
</tr>
<tr>
<td valign="middle" align="center">Metabolic pathways</td>
<td valign="middle" align="center">0.275133</td>
<td valign="middle" align="center">0.746202</td>
<td valign="middle" align="center">ko01100</td>
</tr>
<tr>
<td valign="middle" align="center">Taurine and hypotaurine metabolism</td>
<td valign="middle" align="center">0.303886</td>
<td valign="middle" align="center">0.746202</td>
<td valign="middle" align="center">ko00430</td>
</tr>
<tr>
<td valign="middle" align="center">Riboflavin metabolism</td>
<td valign="middle" align="center">0.303886</td>
<td valign="middle" align="center">0.746202</td>
<td valign="middle" align="center">ko00740</td>
</tr>
<tr>
<td valign="middle" align="center">ABC transporters</td>
<td valign="middle" align="center">0.317148</td>
<td valign="middle" align="center">0.746202</td>
<td valign="middle" align="center">ko02010</td>
</tr>
<tr>
<td valign="middle" align="center">Fatty acid biosynthesis</td>
<td valign="middle" align="center">0.364594</td>
<td valign="middle" align="center">0.746202</td>
<td valign="middle" align="center">ko00061</td>
</tr>
<tr>
<td valign="middle" align="center">Steroid biosynthesis</td>
<td valign="middle" align="center">0.364594</td>
<td valign="middle" align="center">0.746202</td>
<td valign="middle" align="center">ko00100</td>
</tr>
<tr>
<td valign="middle" align="center">Caffeine metabolism</td>
<td valign="middle" align="center">0.364594</td>
<td valign="middle" align="center">0.746202</td>
<td valign="middle" align="center">ko00232</td>
</tr>
<tr>
<td valign="middle" align="center">Valine, leucine and isoleucine biosynthesis</td>
<td valign="middle" align="center">0.364594</td>
<td valign="middle" align="center">0.746202</td>
<td valign="middle" align="center">ko00290</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s3_5">
<label>3.5</label>
<title>Correlation analysis between altered gut microbiota and metabolites</title>
<p>Pearson correlation analysis between the 15 significantly altered gut microbial genera and the 30 differential metabolites identified a network of 71 statistically significant associations (P&lt;0.05, <xref ref-type="fig" rid="f6"><bold>Figure&#xa0;6</bold></xref>). Notably, <italic>Desulfovibrio</italic>, <italic>Prevotella_7</italic>, <italic>Prevotella_9</italic>, and <italic>Lachnospiraceae_XPB1014_group</italic> each exhibited significant correlations with more than eight differential metabolites, while <italic>Streptococcus</italic> and <italic>Leucobacter</italic> correlated with seven and six metabolites, respectively.</p>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>Heat map of correlation between differential flora and differential metabolites. Red represents correlation r&gt;0, which is positive; blue represents correlation r&lt;0, which is negative; &#x201c;*&#x201d; P &lt; 0.05, &#x201c;**&#x201d; P &lt; 0.01, &#x201c;***&#x201d; P &lt; 0.001.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-16-1740531-g006.tif">
<alt-text content-type="machine-generated">Heatmap displaying correlations between various metabolites and microbial genera. Red shades indicate positive correlations, while blue shades represent negative correlations. The scale ranges from negative 0.75 to positive 0.75. Metabolites are listed on the right, and microbial genera are labeled at the bottom. Hierarchical clustering trees are present on both axes, showing relationships among variables.</alt-text>
</graphic></fig>
<p>Of particular relevance to the perturbed arginine biosynthesis pathway, two of its key intermediates showed specific microbial correlations. Argininosuccinate levels were negatively correlated with <italic>Leucobacter</italic> (P&lt;0.05), <italic>Streptococcus</italic> (P&lt;0.05), and <italic>Desulfovibrio</italic> (P&lt;0.05), but positively correlated with <italic>Prevotella_9</italic> (P&lt;0.01). N-Acetylornithine exhibited a negative correlation specifically with <italic>Desulfovibrio</italic> (P&lt;0.05).</p>
</sec>
<sec id="s3_6">
<label>3.6</label>
<title><italic>G. parasuis</italic> infection induces intestinal structural damage and impairs barrier function</title>
<p>Histopathological analysis of the small intestine revealed disorganized intestinal epithelial cells, mild villus damage, and glandular atrophy in infected piglets compared to the well-structured mucosa of uninfected controls (<xref ref-type="fig" rid="f7"><bold>Figure&#xa0;7A</bold></xref>). Morphometric measurements of the intestinal architecture confirmed these observations. In infected piglets, crypt depth in the jejunum was significantly increased (P&lt;0.05), while villus length and the villus-to-crypt (V/C) ratio in the duodenum were significantly reduced (P&lt;0.05). Similar decreasing trends in villus length and villus-to-crypt (V/C) ratio were observed in the ileum, although these did not reach statistical significance (<xref ref-type="fig" rid="f7"><bold>Figure&#xa0;7B</bold></xref>).</p>
<fig id="f7" position="float">
<label>Figure&#xa0;7</label>
<caption>
<p>Intestinal barrier function measurement results. <bold>(A)</bold> Pathology tissue testing. Morphological results of the small intestine and statistical graph of small intestine data. <bold>(B)</bold> The villus-to-crypt (V/C) ratio in the small intestine. <bold>(C)</bold> Serum levels of DAO and D-LA. &#x201c;*&#x201d; P &lt; 0.05 indicates a significant difference between the infected group and the control group.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-16-1740531-g007.tif">
<alt-text content-type="machine-generated">Histological images and graphs illustrate changes in intestinal morphology and serum levels in control versus infected samples. Part A shows stained sections of the jejunum, ileum, and duodenum under control and infected conditions with scale bars of two hundred micrometers. Corresponding bar graphs depict villous length and crypt depth, with significant differences marked by asterisks. Part B presents a graph comparing the villous to crypt length ratio. Part C shows bar graphs of serum diamine oxidase (DAO) and D-lactate (D-LA) levels, indicating significant changes in the infected group.</alt-text>
</graphic></fig>
<p>Consistent with the observed structural damage, serum biomarkers of intestinal barrier integrity were significantly altered. Serum levels of diamine oxidase (DAO) and D-lactate were both significantly elevated in infected piglets (P&lt;0.05) (<xref ref-type="fig" rid="f7"><bold>Figure&#xa0;7C</bold></xref>), indicating increased intestinal permeability.</p>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<label>4</label>
<title>Discussion</title>
<p>Gl&#xe4;sser&#x2019;s disease is widespread globally and causes significant economic losses in the swine industry due to its high mortality rate (<xref ref-type="bibr" rid="B19">Lin et&#xa0;al., 2025</xref>; <xref ref-type="bibr" rid="B39">Yan et&#xa0;al., 2023</xref>). <italic>G. parasuis</italic> is the pathogen responsible for Gl&#xe4;sser&#x2019;s disease, which induces systemic fibrinous inflammation and bacterial pneumonia following infection (<xref ref-type="bibr" rid="B10">Guo et&#xa0;al., 2025</xref>; <xref ref-type="bibr" rid="B46">Zhou et&#xa0;al., 2022</xref>). While traditional research has focused on pathogen serotyping, virulence factors, and host immunity, the dynamic alterations in the host&#x2019;s microbiota during infection remain poorly understood. This study established a piglet infection model with the <italic>G. parasuis</italic> XX0306 strain, providing the first systematic analysis of the concurrent impact of this infection on the pulmonary and intestinal microbial ecosystems, host metabolism, and intestinal barrier integrity. These findings illuminate the systemic pathology of the disease through an integrated microbiota-metabolism-immunity perspective.</p>
<p>The infection induced a marked restructuring of microbial communities. In the lungs, diminished diversity was accompanied by an increased relative abundance of Proteobacteria and a decrease in Firmicutes, a dysbiotic pattern analogous to that observed in chronic obstructive pulmonary disease (<xref ref-type="bibr" rid="B6">Dicker et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B12">Huang et&#xa0;al., 2014</xref>). This shift suggests the infection may foster a pulmonary niche favoring opportunistic pathogens (<xref ref-type="bibr" rid="B5">de Steenhuijsen Piters et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B26">Perez-Cobas et&#xa0;al., 2023</xref>). Corresponding functional predictions indicated a significant downregulation of genes involved in material transport and catabolic metabolism within the lung microbiota. This functional impairment likely compromises local microbial homeostasis and clearance capacity, correlating with the observed severe pulmonary inflammatory pathology.</p>
<p>More profound alterations were evident within the gut microbiota. A significant depletion of beneficial bacterial taxa was noted, including members of the genus <italic>Prevotella</italic> and the family Lachnospiraceae, which are recognized as principal producers of short-chain fatty acids such as butyrate and propionate (<xref ref-type="bibr" rid="B8">Fitzgerald et&#xa0;al., 2025</xref>; <xref ref-type="bibr" rid="B30">Sebastia et&#xa0;al., 2024</xref>). These metabolites serve as the primary energy source for colonocytes, reinforce epithelial barrier function, and facilitate the differentiation of anti-inflammatory regulatory T cells (<xref ref-type="bibr" rid="B27">Ploger et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B29">Saleri et&#xa0;al., 2022</xref>; <xref ref-type="bibr" rid="B34">Takahashi et&#xa0;al., 2020</xref>). Direct evidence confirms that intestinal <italic>Prevotella</italic> colonization helps maintain steady-state levels of SCFAs and promotes the production of the protective cytokine IL-18 in colonic epithelium, which is crucial for barrier integrity and immune tolerance (<xref ref-type="bibr" rid="B13">Iljazovic et&#xa0;al., 2021</xref>). Consequently, the depletion of these bacteria likely represents an active driver of subsequent pathophysiology, leading to SCFA deficiency, diminished intestinal immune signaling, and exacerbated barrier damage. Concurrently, an enrichment of bacteria with potential pathogenic traits was observed. The expansion of <italic>Desulfovibrio</italic>, a producer of epithelial-damaging hydrogen sulfide, and pro-inflammatory <italic>Streptococcus</italic> species may not merely be a consequence of dysbiosis but could actively drive intestinal inflammation and metabolic perturbation. KEGG pathway analysis further revealed a functional recalibration. Reduced gene abundances in amino acid and cofactor metabolism pathways may limit the supply of critical immunonutrients like arginine, while increased abundances in carbohydrate and lipid metabolism genes may reflect nutrient competition by expanding pathobionts or indicate a state of host metabolic stress. This gut dysbiosis signature, characterized by the loss of commensal symbionts and the rise of potential pathogens, mirrors patterns reported following other respiratory infections, suggesting that gut-lung axis disruption may be a common feature of respiratory pathophysiology (<xref ref-type="bibr" rid="B11">Hakansson et&#xa0;al., 2018</xref>).</p>
<p>Non-targeted metabolomic profiling revealed significant disturbances in the intestinal metabolome of infected piglets, with pronounced suppression of the arginine biosynthesis pathway. Levels of the metabolic precursor argininosuccinate were significantly diminished and exhibited correlations with key bacterial taxa, indicating that gut microbiota structural disruption directly modulates host arginine metabolism. Arginine metabolism constitutes a core hub linking microbial dysbiosis to immune compromise. Conventionally, arginine deficiency impairs the host by limiting substrates for nitric oxide synthesis in macrophages and for polyamine production essential for tissue repair (<xref ref-type="bibr" rid="B14">Ji et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B16">Karadima et&#xa0;al., 2025</xref>; <xref ref-type="bibr" rid="B22">Marti and Reith, 2021</xref>). Emerging evidence, however, reveals a competitive dimension to this metabolic disturbance. Pathogens such as <italic>Streptococcus suis</italic> can actively consume host arginine via the arginine deiminase system to fuel their own energy needs and acid resistance, while simultaneously restricting macrophage production of bactericidal nitric oxide (<xref ref-type="bibr" rid="B44">Zhang et&#xa0;al., 2024</xref>). Thus, the observed arginine metabolic inhibition likely represents a vicious cycle of host synthetic deficiency compounded by pathogen consumption. These findings provide a direct rationale for exploring arginine supplementation as a nutritional immunomodulatory strategy. Alterations in the cytochrome P450 pathway indicate a broader dysregulation of metabolic homeostasis under infectious stress, potentially amplifying systemic inflammatory responses.</p>
<p>Histopathological assessment and elevated serum markers of intestinal permeability confirmed significant damage to the intestinal mucosal barrier. This finding crucially links a primary respiratory infection to distal gastrointestinal dysfunction. The breach of intestinal barrier integrity can facilitate the translocation of microbial products, thereby driving a systemic inflammatory response and establishing a vicious cycle of gut leakiness and systemic inflammation (<xref ref-type="bibr" rid="B18">Kinashi and Hase, 2021</xref>; <xref ref-type="bibr" rid="B24">Panpetch et&#xa0;al., 2020</xref>; <xref ref-type="bibr" rid="B44">Zhang et&#xa0;al., 2024</xref>). We propose that pulmonary <italic>G. parasuis</italic> infection disrupts gut homeostasis via the gut-lung axis, involving a cascade of beneficial bacteria depletion, pathobiont expansion, physical barrier disruption, and subsequent microbial translocation, ultimately amplifying multi-organ injury. This pathological cycle finds strong parallel support in other disease models (<xref ref-type="bibr" rid="B2">Budden et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B38">Wypych et&#xa0;al., 2019</xref>). Research in chronic kidney disease has conclusively demonstrated that uremia-induced gut dysbiosis and barrier dysfunction lead to translocation of viable bacteria and endotoxin into the circulation, directly driving persistent systemic inflammation (<xref ref-type="bibr" rid="B35">Vaziri et&#xa0;al., 2016</xref>). Critically, eradication of the dysbiotic microbiota with antibiotics fully reverses all inflammatory markers, establishing a causal relationship (<xref ref-type="bibr" rid="B1">Andersen et&#xa0;al., 2017</xref>). This study provides initial evidence for the existence of a similar integrated pathway in <italic>G. parasuis</italic> pathogenesis.</p>
<p>The present work primarily establishes correlations between microbial shifts and metabolic alterations. To advance beyond association and establish causality, future investigations should employ metagenomic sequencing for higher-resolution functional profiling and conduct targeted quantification of key metabolites, including short-chain fatty acids and arginine pathway intermediates. <italic>In vitro</italic> models utilizing intestinal organoids or epithelial-immune cell co-cultures would be valuable for directly testing the effects of specific bacterial taxa or their metabolic products on barrier function and immune activation. Finally, interventional animal studies evaluating the therapeutic potential of butyrate, arginine, or defined probiotic consortia against <italic>G. parasuis</italic> infection are essential to translate these mechanistic insights into practical strategies for disease control.</p>
</sec>
</body>
<back>
<sec id="s5" sec-type="data-availability">
<title>Data availability statement</title>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found below: <uri xlink:href="https://www.ncbi.nlm.nih.gov/">https://www.ncbi.nlm.nih.gov/</uri>, PRJNA1283987 <uri xlink:href="https://www.ebi.ac.uk/metabolights/">https://www.ebi.ac.uk/metabolights/</uri>, MTBLS12802.</p></sec>
<sec id="s6" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The animal study was approved by the Ethical Review Committee and Laboratory Animal Welfare Committee of Shenyang Agricultural University. The study was conducted in accordance with the local legislation and institutional requirements.</p></sec>
<sec id="s7" sec-type="author-contributions">
<title>Author contributions</title>
<p>NL: Conceptualization, Methodology, Validation, Writing &#x2013; original draft. AS: Conceptualization, Methodology, Validation, Writing &#x2013; original draft. XS: Data curation, Investigation, Validation, Writing &#x2013; original draft. YG: Formal analysis, Project administration, Validation, Writing &#x2013; original draft. RLY: Project administration, Supervision, Writing &#x2013; review &amp; editing. MQ: Data curation, Investigation, Validation, Writing &#x2013; original draft. FZ: Data curation, Investigation, Validation, Writing &#x2013; original draft. HW: Formal analysis, Visualization, Writing &#x2013; original draft. XL: Formal analysis, Visualization, Writing &#x2013; original draft. ML: Formal analysis, Visualization, Writing &#x2013; original draft. YZ: Project administration, Resources, Supervision, Writing &#x2013; review &amp; editing. RHY: Project administration, Resources, Supervision, Writing &#x2013; review &amp; editing.</p></sec>
<ack>
<title>Acknowledgments</title>
<p>The authors are grateful to the support and assistance in terms of instruments and facilities provided by Key Laboratory of Livestock Infectious Diseases, Ministry of Education, and Key Laboratory of Ruminant Infectious Disease Prevention and Control (East), Ministry of Agriculture and Rural Affairs, College of Animal Science and Veterinary Medicine, Shenyang Agricultural University, 120 Dongling Road, Shenyang 110866, China.</p>
</ack>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec>
<sec id="s10" sec-type="ai-statement">
<title>Generative AI statement</title>
<p>The author(s) declared that generative AI was not used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p></sec>
<sec id="s11" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Andersen</surname> <given-names>K.</given-names></name>
<name><surname>Kesper</surname> <given-names>M. S.</given-names></name>
<name><surname>Marschner</surname> <given-names>J. A.</given-names></name>
<name><surname>Konrad</surname> <given-names>L.</given-names></name>
<name><surname>Ryu</surname> <given-names>M.</given-names></name>
<name><surname>Kumar Vr</surname> <given-names>S.</given-names></name>
<etal/>
</person-group>. (<year>2017</year>). 
<article-title>Intestinal dysbiosis, barrier dysfunction, and bacterial translocation account for CKD-related systemic inflammation</article-title>. <source>J. Am. Soc. Nephrol.</source> <volume>28</volume>, <fpage>76</fpage>&#x2013;<lpage>83</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1681/ASN.2015111285</pub-id>, PMID: <pub-id pub-id-type="pmid">27151924</pub-id>
</mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Budden</surname> <given-names>K. F.</given-names></name>
<name><surname>Gellatly</surname> <given-names>S. L.</given-names></name>
<name><surname>Wood</surname> <given-names>D. L.</given-names></name>
<name><surname>Cooper</surname> <given-names>M. A.</given-names></name>
<name><surname>Morrison</surname> <given-names>M.</given-names></name>
<name><surname>Hugenholtz</surname> <given-names>P.</given-names></name>
<etal/>
</person-group>. (<year>2017</year>). 
<article-title>Emerging pathogenic links between microbiota and the gut-lung axis</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>15</volume>, <fpage>55</fpage>&#x2013;<lpage>63</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nrmicro.2016.142</pub-id>, PMID: <pub-id pub-id-type="pmid">27694885</pub-id>
</mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Dang</surname> <given-names>A. T.</given-names></name>
<name><surname>Marsland</surname> <given-names>B. J.</given-names></name>
</person-group> (<year>2019</year>). 
<article-title>Microbes, metabolites, and the gut-lung axis</article-title>. <source>Mucosal Immunol.</source> <volume>12</volume>, <fpage>843</fpage>&#x2013;<lpage>850</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41385-019-0160-6</pub-id>, PMID: <pub-id pub-id-type="pmid">30976087</pub-id>
</mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Dazzi</surname> <given-names>C. C.</given-names></name>
<name><surname>Guizzo</surname> <given-names>J. A.</given-names></name>
<name><surname>Prigol</surname> <given-names>S. R.</given-names></name>
<name><surname>Kreutz</surname> <given-names>L. C.</given-names></name>
<name><surname>Driemeier</surname> <given-names>D.</given-names></name>
<name><surname>Chaudhuri</surname> <given-names>S.</given-names></name>
<etal/>
</person-group>. (<year>2020</year>). 
<article-title>New pathological lesions developed in pigs by a &#x201c;Non-virulent&#x201d; Strain of glaesserella parasuis</article-title>. <source>Front. Vet. Sci.</source> <volume>7</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fvets.2020.00098</pub-id>, PMID: <pub-id pub-id-type="pmid">32158772</pub-id>
</mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>de Steenhuijsen Piters</surname> <given-names>W. A.</given-names></name>
<name><surname>Sanders</surname> <given-names>E. A.</given-names></name>
<name><surname>Bogaert</surname> <given-names>D.</given-names></name>
</person-group> (<year>2015</year>). 
<article-title>The role of the local microbial ecosystem in respiratory health and disease</article-title>. <source>Philos. Trans. R Soc. Lond B Biol. Sci.</source> <volume>370</volume>, <fpage>20140294</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1098/rstb.2014.0294</pub-id>, PMID: <pub-id pub-id-type="pmid">26150660</pub-id>
</mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Dicker</surname> <given-names>A. J.</given-names></name>
<name><surname>Huang</surname> <given-names>J. T. J.</given-names></name>
<name><surname>Lonergan</surname> <given-names>M.</given-names></name>
<name><surname>Keir</surname> <given-names>H. R.</given-names></name>
<name><surname>Fong</surname> <given-names>C. J.</given-names></name>
<name><surname>Tan</surname> <given-names>B.</given-names></name>
<etal/>
</person-group>. (<year>2021</year>). 
<article-title>The sputum microbiome, airway inflammation, and mortality in chronic obstructive pulmonary disease</article-title>. <source>J. Allergy Clin. Immunol.</source> <volume>147</volume>, <fpage>158</fpage>&#x2013;<lpage>167</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jaci.2020.02.040</pub-id>, PMID: <pub-id pub-id-type="pmid">32353489</pub-id>
</mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Espirito Santo</surname> <given-names>C.</given-names></name>
<name><surname>Caseiro</surname> <given-names>C.</given-names></name>
<name><surname>Martins</surname> <given-names>M. J.</given-names></name>
<name><surname>Monteiro</surname> <given-names>R.</given-names></name>
<name><surname>Brandao</surname> <given-names>I.</given-names></name>
</person-group> (<year>2021</year>). 
<article-title>Gut microbiota, in the halfway between nutrition and lung function</article-title>. <source>Nutrients</source> <volume>13</volume>, <elocation-id>1716</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/nu13051716</pub-id>, PMID: <pub-id pub-id-type="pmid">34069415</pub-id>
</mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Fitzgerald</surname> <given-names>B. G.</given-names></name>
<name><surname>Govind</surname> <given-names>M.</given-names></name>
<name><surname>Firth</surname> <given-names>I. J.</given-names></name>
<name><surname>Herold</surname> <given-names>L.</given-names></name>
<name><surname>Froment</surname> <given-names>J.</given-names></name>
<name><surname>Vancuren</surname> <given-names>S. J.</given-names></name>
<etal/>
</person-group>. (<year>2025</year>). 
<article-title>Members of Lachnospiraceae produce valerate and caproate in response to short-chain fatty acids</article-title>. <source>Microbiome</source> <volume>13</volume>, <fpage>201</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s40168-025-02220-9</pub-id>, PMID: <pub-id pub-id-type="pmid">41057964</pub-id>
</mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Gong</surname> <given-names>H.</given-names></name>
<name><surname>Chen</surname> <given-names>L.</given-names></name>
<name><surname>He</surname> <given-names>Y.</given-names></name>
<name><surname>Hua</surname> <given-names>K.</given-names></name>
<name><surname>Ma</surname> <given-names>B.</given-names></name>
<name><surname>Gao</surname> <given-names>Y.</given-names></name>
<etal/>
</person-group>. (<year>2022</year>). 
<article-title>Pleural thickening induced by Glaesserella parasuis infection was linked to increased collagen and elastin</article-title>. <source>Front. Cell Infect. Microbiol.</source> <volume>12</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2022.952377</pub-id>, PMID: <pub-id pub-id-type="pmid">36034702</pub-id>
</mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Guo</surname> <given-names>Z.</given-names></name>
<name><surname>Zhou</surname> <given-names>Y.</given-names></name>
<name><surname>Li</surname> <given-names>N.</given-names></name>
<name><surname>Shen</surname> <given-names>A.</given-names></name>
<name><surname>Jia</surname> <given-names>Y.</given-names></name>
<name><surname>Yin</surname> <given-names>R.</given-names></name>
<etal/>
</person-group>. (<year>2025</year>). 
<article-title>The Molecular Mechanism by Which miR-129a-3p Targets the TLR4/NF-kappaB Signaling Pathway to Regulate Inflammatory Damage in 3D4/21 Cells Infected with Glaesserella parasuis</article-title>. <source>Anim. (Basel)</source> <volume>15</volume>, <elocation-id>1355</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ani15101355</pub-id>, PMID: <pub-id pub-id-type="pmid">40427234</pub-id>
</mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Hakansson</surname> <given-names>A. P.</given-names></name>
<name><surname>Orihuela</surname> <given-names>C. J.</given-names></name>
<name><surname>Bogaert</surname> <given-names>D.</given-names></name>
</person-group> (<year>2018</year>). 
<article-title>Bacterial-host interactions: physiology and pathophysiology of respiratory infection</article-title>. <source>Physiol. Rev.</source> <volume>98</volume>, <fpage>781</fpage>&#x2013;<lpage>811</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1152/physrev.00040.2016</pub-id>, PMID: <pub-id pub-id-type="pmid">29488821</pub-id>
</mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Huang</surname> <given-names>Y. J.</given-names></name>
<name><surname>Sethi</surname> <given-names>S.</given-names></name>
<name><surname>Murphy</surname> <given-names>T.</given-names></name>
<name><surname>Nariya</surname> <given-names>S.</given-names></name>
<name><surname>Boushey</surname> <given-names>H. A.</given-names></name>
<name><surname>Lynch</surname> <given-names>S. V.</given-names></name>
</person-group> (<year>2014</year>). 
<article-title>Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease</article-title>. <source>J. Clin. Microbiol.</source> <volume>52</volume>, <fpage>2813</fpage>&#x2013;<lpage>2823</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/JCM.00035-14</pub-id>, PMID: <pub-id pub-id-type="pmid">24850358</pub-id>
</mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Iljazovic</surname> <given-names>A.</given-names></name>
<name><surname>Roy</surname> <given-names>U.</given-names></name>
<name><surname>Galvez</surname> <given-names>E. J. C.</given-names></name>
<name><surname>Lesker</surname> <given-names>T. R.</given-names></name>
<name><surname>Zhao</surname> <given-names>B.</given-names></name>
<name><surname>Gronow</surname> <given-names>A.</given-names></name>
<etal/>
</person-group>. (<year>2021</year>). 
<article-title>Perturbation of the gut microbiome by Prevotella spp. enhances host susceptibility to mucosal inflammation</article-title>. <source>Mucosal Immunol.</source> <volume>14</volume>, <fpage>113</fpage>&#x2013;<lpage>124</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41385-020-0296-4</pub-id>, PMID: <pub-id pub-id-type="pmid">32433514</pub-id>
</mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ji</surname> <given-names>L.</given-names></name>
<name><surname>Zhao</surname> <given-names>X.</given-names></name>
<name><surname>Zhang</surname> <given-names>B.</given-names></name>
<name><surname>Kang</surname> <given-names>L.</given-names></name>
<name><surname>Song</surname> <given-names>W.</given-names></name>
<name><surname>Zhao</surname> <given-names>B.</given-names></name>
<etal/>
</person-group>. (<year>2019</year>). 
<article-title>Slc6a8-mediated creatine uptake and accumulation reprogram macrophage polarization via regulating cytokine responses</article-title>. <source>Immunity</source> <volume>51</volume>: <fpage>272</fpage>&#x2013;<lpage>284</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.immuni.2019.06.007</pub-id>, PMID: <pub-id pub-id-type="pmid">31399282</pub-id>
</mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Jia</surname> <given-names>Y.</given-names></name>
<name><surname>Qian</surname> <given-names>M.</given-names></name>
<name><surname>Sun</surname> <given-names>X.</given-names></name>
<name><surname>Yin</surname> <given-names>R.</given-names></name>
<name><surname>Li</surname> <given-names>N.</given-names></name>
<name><surname>Shen</surname> <given-names>A.</given-names></name>
<etal/>
</person-group>. (<year>2025</year>). 
<article-title>LncRNA MEG3 Regulates Glaesserella parasuis-Induced Apoptosis of Porcine Alveolar Macrophages via Regulating ssc-miR-135/CASP8 Axis</article-title>. <source>Microorganisms</source> <volume>13</volume>, <elocation-id>2287</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/microorganisms13102287</pub-id>, PMID: <pub-id pub-id-type="pmid">41156747</pub-id>
</mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Karadima</surname> <given-names>E.</given-names></name>
<name><surname>Chavakis</surname> <given-names>T.</given-names></name>
<name><surname>Alexaki</surname> <given-names>V. I.</given-names></name>
</person-group> (<year>2025</year>). 
<article-title>Arginine metabolism in myeloid cells in health and disease</article-title>. <source>Semin. Immunopathol.</source> <volume>47</volume>, <fpage>11</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00281-025-01038-9</pub-id>, PMID: <pub-id pub-id-type="pmid">39863828</pub-id>
</mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kim</surname> <given-names>M. H.</given-names></name>
<name><surname>Kang</surname> <given-names>S. G.</given-names></name>
<name><surname>Park</surname> <given-names>J. H.</given-names></name>
<name><surname>Yanagisawa</surname> <given-names>M.</given-names></name>
<name><surname>Kim</surname> <given-names>C. H.</given-names></name>
</person-group> (<year>2013</year>). 
<article-title>Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice</article-title>. <source>Gastroenterology</source> <volume>145</volume>: <fpage>396</fpage>&#x2013;<lpage>406</lpage> . doi:&#xa0;<pub-id pub-id-type="doi">10.1053/j.gastro.2013.04.056</pub-id>, PMID: <pub-id pub-id-type="pmid">23665276</pub-id>
</mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kinashi</surname> <given-names>Y.</given-names></name>
<name><surname>Hase</surname> <given-names>K.</given-names></name>
</person-group> (<year>2021</year>). 
<article-title>Partners in leaky gut syndrome: intestinal dysbiosis and autoimmunity</article-title>. <source>Front. Immunol.</source> <volume>12</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2021.673708</pub-id>, PMID: <pub-id pub-id-type="pmid">33968085</pub-id>
</mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Lin</surname> <given-names>W. H.</given-names></name>
<name><surname>Liou</surname> <given-names>Z. W.</given-names></name>
<name><surname>Lin</surname> <given-names>S. M.</given-names></name>
<name><surname>Yang</surname> <given-names>C. Y.</given-names></name>
<name><surname>Lin</surname> <given-names>C. F.</given-names></name>
<name><surname>Chang</surname> <given-names>Y. F.</given-names></name>
<etal/>
</person-group>. (<year>2025</year>). 
<article-title>Comparison of antimicrobial susceptibility of Glaesserella parasuis from different pig production systems in Taiwan between 2015 and 2020</article-title>. <source>Porcine Health Manag</source> <volume>11</volume>, <fpage>15</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s40813-025-00427-8</pub-id>, PMID: <pub-id pub-id-type="pmid">40102942</pub-id>
</mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Liu</surname> <given-names>J.</given-names></name>
<name><surname>Huang</surname> <given-names>Y.</given-names></name>
<name><surname>Liu</surname> <given-names>N.</given-names></name>
<name><surname>Qiu</surname> <given-names>H.</given-names></name>
<name><surname>Zhang</surname> <given-names>X.</given-names></name>
<name><surname>Liu</surname> <given-names>X.</given-names></name>
<etal/>
</person-group>. (<year>2024</year>). 
<article-title>The imbalance of pulmonary Th17/Treg cells in BALB/c suckling mice infected with respiratory syncytial virus-mediated intestinal immune damage and gut microbiota changes</article-title>. <source>Microbiol. Spectr.</source> <volume>12</volume>, <fpage>e0181224</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/spectrum.01812-24</pub-id>, PMID: <pub-id pub-id-type="pmid">39207148</pub-id>
</mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Mahmmod</surname> <given-names>Y. S.</given-names></name>
<name><surname>Correa-Fiz</surname> <given-names>F.</given-names></name>
<name><surname>Aragon</surname> <given-names>V.</given-names></name>
</person-group> (<year>2020</year>). 
<article-title>Variations in association of nasal microbiota with virulent and non-virulent strains of Glaesserella (Hemophilus) parasuis in weaning piglets</article-title>. <source>Vet. Res.</source> <volume>51</volume>, <elocation-id>7</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13567-020-0738-8</pub-id>, PMID: <pub-id pub-id-type="pmid">32014043</pub-id>
</mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Marti</surname> <given-names>I. L. A. A.</given-names></name>
<name><surname>Reith</surname> <given-names>W.</given-names></name>
</person-group> (<year>2021</year>). 
<article-title>Arginine-dependent immune responses</article-title>. <source>Cell Mol. Life Sci.</source> <volume>78</volume>, <fpage>5303</fpage>&#x2013;<lpage>5324</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00018-021-03828-4</pub-id>, PMID: <pub-id pub-id-type="pmid">34037806</pub-id>
</mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Obregon-Gutierrez</surname> <given-names>P.</given-names></name>
<name><surname>Mahmmod</surname> <given-names>Y.</given-names></name>
<name><surname>Barba-Vidal</surname> <given-names>E.</given-names></name>
<name><surname>Sibila</surname> <given-names>M.</given-names></name>
<name><surname>Correa-Fiz</surname> <given-names>F.</given-names></name>
<name><surname>Aragon</surname> <given-names>V.</given-names></name>
</person-group> (<year>2025</year>). 
<article-title>Pig nasal and rectal microbiotas are involved in the antibody response to Glaesserella parasuis</article-title>. <source>Sci. Rep.</source> <volume>15</volume>, <fpage>2347</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-025-85867-6</pub-id>, PMID: <pub-id pub-id-type="pmid">39824862</pub-id>
</mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Panpetch</surname> <given-names>W.</given-names></name>
<name><surname>Hiengrach</surname> <given-names>P.</given-names></name>
<name><surname>Nilgate</surname> <given-names>S.</given-names></name>
<name><surname>Tumwasorn</surname> <given-names>S.</given-names></name>
<name><surname>Somboonna</surname> <given-names>N.</given-names></name>
<name><surname>Wilantho</surname> <given-names>A.</given-names></name>
<etal/>
</person-group>. (<year>2020</year>). 
<article-title>Additional Candida albicans administration enhances the severity of dextran sulfate solution induced colitis mouse model through leaky gut-enhanced systemic inflammation and gut-dysbiosis but attenuated by Lactobacillus rhamnosus L34</article-title>. <source>Gut Microbes</source> <volume>11</volume>, <fpage>465</fpage>&#x2013;<lpage>480</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/19490976.2019.1662712</pub-id>, PMID: <pub-id pub-id-type="pmid">31530137</pub-id>
</mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Park</surname> <given-names>J.</given-names></name>
<name><surname>Kim</surname> <given-names>M.</given-names></name>
<name><surname>Kang</surname> <given-names>S. G.</given-names></name>
<name><surname>Jannasch</surname> <given-names>A. H.</given-names></name>
<name><surname>Cooper</surname> <given-names>B.</given-names></name>
<name><surname>Patterson</surname> <given-names>J.</given-names></name>
<etal/>
</person-group>. (<year>2015</year>). 
<article-title>Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway</article-title>. <source>Mucosal Immunol.</source> <volume>8</volume>, <fpage>80</fpage>&#x2013;<lpage>93</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/mi.2014.44</pub-id>, PMID: <pub-id pub-id-type="pmid">24917457</pub-id>
</mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Perez-Cobas</surname> <given-names>A. E.</given-names></name>
<name><surname>Ginevra</surname> <given-names>C.</given-names></name>
<name><surname>Rusniok</surname> <given-names>C.</given-names></name>
<name><surname>Jarraud</surname> <given-names>S.</given-names></name>
<name><surname>Buchrieser</surname> <given-names>C.</given-names></name>
</person-group> (<year>2023</year>). 
<article-title>The respiratory tract microbiome, the pathogen load, and clinical interventions define severity of bacterial pneumonia</article-title>. <source>Cell Rep. Med.</source> <volume>4</volume>, <elocation-id>101167</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.xcrm.2023.101167</pub-id>, PMID: <pub-id pub-id-type="pmid">37633274</pub-id>
</mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ploger</surname> <given-names>S.</given-names></name>
<name><surname>Stumpff</surname> <given-names>F.</given-names></name>
<name><surname>Penner</surname> <given-names>G. B.</given-names></name>
<name><surname>Schulzke</surname> <given-names>J. D.</given-names></name>
<name><surname>Gabel</surname> <given-names>G.</given-names></name>
<name><surname>Martens</surname> <given-names>H.</given-names></name>
<etal/>
</person-group>. (<year>2012</year>). 
<article-title>Microbial butyrate and its role for barrier function in the gastrointestinal tract</article-title>. <source>Ann. N Y Acad. Sci.</source> <volume>1258</volume>, <fpage>52</fpage>&#x2013;<lpage>59</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1749-6632.2012.06553.x</pub-id>, PMID: <pub-id pub-id-type="pmid">22731715</pub-id>
</mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Qayed</surname> <given-names>M.</given-names></name>
<name><surname>Michonneau</surname> <given-names>D.</given-names></name>
<name><surname>Socie</surname> <given-names>G.</given-names></name>
<name><surname>Waller</surname> <given-names>E. K.</given-names></name>
</person-group> (<year>2021</year>). 
<article-title>Indole derivatives, microbiome and graft versus host disease</article-title>. <source>Curr. Opin. Immunol.</source> <volume>70</volume>, <fpage>40</fpage>&#x2013;<lpage>47</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.coi.2021.02.006</pub-id>, PMID: <pub-id pub-id-type="pmid">33647539</pub-id>
</mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Saleri</surname> <given-names>R.</given-names></name>
<name><surname>Borghetti</surname> <given-names>P.</given-names></name>
<name><surname>Ravanetti</surname> <given-names>F.</given-names></name>
<name><surname>Cavalli</surname> <given-names>V.</given-names></name>
<name><surname>Ferrari</surname> <given-names>L.</given-names></name>
<name><surname>De Angelis</surname> <given-names>E.</given-names></name>
<etal/>
</person-group>. (<year>2022</year>). 
<article-title>Effects of different short-chain fatty acids (SCFA) on gene expression of proteins involved in barrier function in IPEC-J2</article-title>. <source>Porcine Health Manag</source> <volume>8</volume>, <fpage>21</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s40813-022-00264-z</pub-id>, PMID: <pub-id pub-id-type="pmid">35590351</pub-id>
</mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Sebastia</surname> <given-names>C.</given-names></name>
<name><surname>Folch</surname> <given-names>J. M.</given-names></name>
<name><surname>Ballester</surname> <given-names>M.</given-names></name>
<name><surname>Estelle</surname> <given-names>J.</given-names></name>
<name><surname>Passols</surname> <given-names>M.</given-names></name>
<name><surname>Munoz</surname> <given-names>M.</given-names></name>
<etal/>
</person-group>. (<year>2024</year>). 
<article-title>Interrelation between gut microbiota, SCFA, and fatty acid composition in pigs</article-title>. <source>mSystems</source> <volume>9</volume>, <fpage>e0104923</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/msystems.01049-23</pub-id>, PMID: <pub-id pub-id-type="pmid">38095419</pub-id>
</mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Sencio</surname> <given-names>V.</given-names></name>
<name><surname>MaChado</surname> <given-names>M. G.</given-names></name>
<name><surname>Trottein</surname> <given-names>F.</given-names></name>
</person-group> (<year>2021</year>). 
<article-title>The lung-gut axis during viral respiratory infections: the impact of gut dysbiosis on secondary disease outcomes</article-title>. <source>Mucosal Immunol.</source> <volume>14</volume>, <fpage>296</fpage>&#x2013;<lpage>304</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41385-020-00361-8</pub-id>, PMID: <pub-id pub-id-type="pmid">33500564</pub-id>
</mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Shim</surname> <given-names>J. A.</given-names></name>
<name><surname>Ryu</surname> <given-names>J. H.</given-names></name>
<name><surname>Jo</surname> <given-names>Y.</given-names></name>
<name><surname>Hong</surname> <given-names>C.</given-names></name>
</person-group> (<year>2023</year>). 
<article-title>The role of gut microbiota in T cell immunity and immune mediated disorders</article-title>. <source>Int. J. Biol. Sci.</source> <volume>19</volume>, <fpage>1178</fpage>&#x2013;<lpage>1191</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.7150/ijbs.79430</pub-id>, PMID: <pub-id pub-id-type="pmid">36923929</pub-id>
</mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Stevens</surname> <given-names>J.</given-names></name>
<name><surname>Steinmeyer</surname> <given-names>S.</given-names></name>
<name><surname>Bonfield</surname> <given-names>M.</given-names></name>
<name><surname>Peterson</surname> <given-names>L.</given-names></name>
<name><surname>Wang</surname> <given-names>T.</given-names></name>
<name><surname>Gray</surname> <given-names>J.</given-names></name>
<etal/>
</person-group>. (<year>2022</year>). 
<article-title>The balance between protective and pathogenic immune responses to pneumonia in the neonatal lung is enforced by gut microbiota</article-title>. <source>Sci. Transl. Med.</source> <volume>14</volume>, <fpage>eabl3981</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/scitranslmed.abl3981</pub-id>, PMID: <pub-id pub-id-type="pmid">35704600</pub-id>
</mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Takahashi</surname> <given-names>D.</given-names></name>
<name><surname>Hoshina</surname> <given-names>N.</given-names></name>
<name><surname>Kabumoto</surname> <given-names>Y.</given-names></name>
<name><surname>Maeda</surname> <given-names>Y.</given-names></name>
<name><surname>Suzuki</surname> <given-names>A.</given-names></name>
<name><surname>Tanabe</surname> <given-names>H.</given-names></name>
<etal/>
</person-group>. (<year>2020</year>). 
<article-title>Microbiota-derived butyrate limits the autoimmune response by promoting the differentiation of follicular regulatory T cells</article-title>. <source>EBioMedicine</source> <volume>58</volume>, <elocation-id>102913</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ebiom.2020.102913</pub-id>, PMID: <pub-id pub-id-type="pmid">32711255</pub-id>
</mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Vaziri</surname> <given-names>N. D.</given-names></name>
<name><surname>Zhao</surname> <given-names>Y. Y.</given-names></name>
<name><surname>Pahl</surname> <given-names>M. V.</given-names></name>
</person-group> (<year>2016</year>). 
<article-title>Altered intestinal microbial flora and impaired epithelial barrier structure and function in CKD: the nature, mechanisms, consequences and potential treatment</article-title>. <source>Nephrol. Dial Transplant.</source> <volume>31</volume>, <fpage>737</fpage>&#x2013;<lpage>746</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/ndt/gfv095</pub-id>, PMID: <pub-id pub-id-type="pmid">25883197</pub-id>
</mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname> <given-names>L. L.</given-names></name>
<name><surname>Shen</surname> <given-names>X.</given-names></name>
<name><surname>Xie</surname> <given-names>Y.</given-names></name>
<name><surname>Ge</surname> <given-names>A.</given-names></name>
<name><surname>Lu</surname> <given-names>H.</given-names></name>
<name><surname>Gu</surname> <given-names>S.</given-names></name>
<etal/>
</person-group>. (<year>2025</year>). 
<article-title>A gut Eggerthella lenta-derived metabolite impairs neutrophil function to aggravate bacterial lung infection</article-title>. <source>Sci. Transl. Med.</source> <volume>17</volume>, <fpage>eadq4409</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/scitranslmed.adq4409</pub-id>, PMID: <pub-id pub-id-type="pmid">40009694</pub-id>
</mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wei</surname> <given-names>Y. H.</given-names></name>
<name><surname>Ma</surname> <given-names>X.</given-names></name>
<name><surname>Zhao</surname> <given-names>J. C.</given-names></name>
<name><surname>Wang</surname> <given-names>X. Q.</given-names></name>
<name><surname>Gao</surname> <given-names>C. Q.</given-names></name>
</person-group> (<year>2023</year>). 
<article-title>Succinate metabolism and its regulation of host-microbe interactions</article-title>. <source>Gut Microbes</source> <volume>15</volume>, <elocation-id>2190300</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/19490976.2023.2190300</pub-id>, PMID: <pub-id pub-id-type="pmid">36946592</pub-id>
</mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wypych</surname> <given-names>T. P.</given-names></name>
<name><surname>Wickramasinghe</surname> <given-names>L. C.</given-names></name>
<name><surname>Marsland</surname> <given-names>B. J.</given-names></name>
</person-group> (<year>2019</year>). 
<article-title>The influence of the microbiome on respiratory health</article-title>. <source>Nat. Immunol.</source> <volume>20</volume>, <fpage>1279</fpage>&#x2013;<lpage>1290</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41590-019-0451-9</pub-id>, PMID: <pub-id pub-id-type="pmid">31501577</pub-id>
</mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Yan</surname> <given-names>P.</given-names></name>
<name><surname>Jia</surname> <given-names>Y. C.</given-names></name>
<name><surname>Zhang</surname> <given-names>X. L.</given-names></name>
<name><surname>Zhou</surname> <given-names>Y. Y.</given-names></name>
<name><surname>Guo</surname> <given-names>Y.</given-names></name>
<name><surname>Yin</surname> <given-names>R. L.</given-names></name>
<etal/>
</person-group>. (<year>2023</year>). 
<article-title>Virulence assessment of four Glaesserella parasuis strains isolated in Liaoning province of China</article-title>. <source>Res. Vet. Sci.</source> <volume>158</volume>, <fpage>226</fpage>&#x2013;<lpage>234</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.rvsc.2023.03.021</pub-id>, PMID: <pub-id pub-id-type="pmid">37031471</pub-id>
</mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Yoo</surname> <given-names>J. Y.</given-names></name>
<name><surname>Groer</surname> <given-names>M.</given-names></name>
<name><surname>Dutra</surname> <given-names>S. V. O.</given-names></name>
<name><surname>Sarkar</surname> <given-names>A.</given-names></name>
<name><surname>McSkimming</surname> <given-names>D. I.</given-names></name>
</person-group> (<year>2020</year>). 
<article-title>Gut microbiota and immune system interactions</article-title>. <source>Microorganisms</source> <volume>8</volume>, <elocation-id>2046</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/microorganisms8122046</pub-id>, PMID: <pub-id pub-id-type="pmid">33371530</pub-id>
</mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Yoon</surname> <given-names>J. H.</given-names></name>
<name><surname>Do</surname> <given-names>J. S.</given-names></name>
<name><surname>Velankanni</surname> <given-names>P.</given-names></name>
<name><surname>Lee</surname> <given-names>C. G.</given-names></name>
<name><surname>Kwon</surname> <given-names>H. K.</given-names></name>
</person-group> (<year>2023</year>). 
<article-title>Gut microbial metabolites on host immune responses in health and disease</article-title>. <source>Immune Netw.</source> <volume>23</volume>, <elocation-id>e6</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.4110/in.2023.23.e6</pub-id>, PMID: <pub-id pub-id-type="pmid">36911800</pub-id>
</mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Yu</surname> <given-names>L.</given-names></name>
<name><surname>Zhang</surname> <given-names>C.</given-names></name>
<name><surname>Zhai</surname> <given-names>Q.</given-names></name>
</person-group> (<year>2024</year>). 
<article-title>Gut microbes participate in host polyamine metabolism</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>121</volume>, <fpage>e2419368121</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.2419368121</pub-id>, PMID: <pub-id pub-id-type="pmid">39467143</pub-id>
</mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Zhang</surname> <given-names>Y.</given-names></name>
<name><surname>Gan</surname> <given-names>Y.</given-names></name>
<name><surname>Wang</surname> <given-names>J.</given-names></name>
<name><surname>Feng</surname> <given-names>Z.</given-names></name>
<name><surname>Zhong</surname> <given-names>Z.</given-names></name>
<name><surname>Bao</surname> <given-names>H.</given-names></name>
<etal/>
</person-group>. (<year>2022</year>). 
<article-title>Dysbiosis of gut microbiota and intestinal barrier dysfunction in pigs with pulmonary inflammation induced by mycoplasma hyorhinis infection</article-title>. <source>mSystems</source> <volume>7</volume>, <fpage>e0028222</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/msystems.00282-22</pub-id>, PMID: <pub-id pub-id-type="pmid">35699454</pub-id>
</mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Zhang</surname> <given-names>Y.</given-names></name>
<name><surname>Liang</surname> <given-names>S.</given-names></name>
<name><surname>Zhang</surname> <given-names>S.</given-names></name>
<name><surname>Bai</surname> <given-names>Q.</given-names></name>
<name><surname>Dai</surname> <given-names>L.</given-names></name>
<name><surname>Wang</surname> <given-names>J.</given-names></name>
<etal/>
</person-group>. (<year>2024</year>). 
<article-title>Streptococcal arginine deiminase system defenses macrophage bactericidal effect mediated by XRE family protein XtrSs</article-title>. <source>Virulence</source> <volume>15</volume>, <elocation-id>2306719</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/21505594.2024.2306719</pub-id>, PMID: <pub-id pub-id-type="pmid">38251714</pub-id>
</mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Zhao</surname> <given-names>H.</given-names></name>
<name><surname>Wang</surname> <given-names>D.</given-names></name>
<name><surname>Zhang</surname> <given-names>Z.</given-names></name>
<name><surname>Xian</surname> <given-names>J.</given-names></name>
<name><surname>Bai</surname> <given-names>X.</given-names></name>
</person-group> (<year>2022</year>). 
<article-title>Effect of gut microbiota-derived metabolites on immune checkpoint inhibitor therapy: enemy or friend</article-title>? <source>Molecules</source> <volume>27</volume>, <elocation-id>4799</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/molecules27154799</pub-id>, PMID: <pub-id pub-id-type="pmid">35956752</pub-id>
</mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Zhou</surname> <given-names>Y. Y.</given-names></name>
<name><surname>Yuan</surname> <given-names>J.</given-names></name>
<name><surname>Jia</surname> <given-names>Y. C.</given-names></name>
<name><surname>Guo</surname> <given-names>Y.</given-names></name>
<name><surname>Yin</surname> <given-names>R. L.</given-names></name>
<name><surname>Guo</surname> <given-names>Z. B.</given-names></name>
<etal/>
</person-group>. (<year>2022</year>). 
<article-title>Transcriptomics analysis reveals key lncRNAs and genes related to the infection of porcine lung macrophages by Glaesserella parasuis</article-title>. <source>Microb. Pathog.</source> <volume>169</volume>, <elocation-id>105617</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.micpath.2022.105617</pub-id>, PMID: <pub-id pub-id-type="pmid">35680006</pub-id>
</mixed-citation>
</ref>
</ref-list>
<fn-group>
<fn id="n1" fn-type="custom" custom-type="edited-by">
<p>Edited by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/459142">Guiyan Yang</ext-link>, China Agricultural University, China</p></fn>
<fn id="n2" fn-type="custom" custom-type="reviewed-by">
<p>Reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2182721">Sergi L&#xf3;pez-Serrano</ext-link>, Pompeu Fabra University, Spain</p>
<p><ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2717757">Liumei Sun</ext-link>, Jiangsu University of Science and Technology, China</p></fn>
</fn-group>
</back>
</article>